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Abstract 
  The genetic blueprint of  all living organisms, whether unicellular (e.g. bacteria) or 
multicellular (e.g. human) is encoded by its genome. One of  the most fundamental 
challenges of  the cell is to accurately copy and transmit its genome to daughter cells. In 
addition, during their life cycle cells are often exposed to many forms of  DNA replication 
stress and DNA damage, and combat this via the complex network of  interconnected 
pathways, named the DNA damage response (DDR). If  this process goes awry, genomic 
instability develops and, depending on specific mechanisms involved, presents in various 
forms and represents a major hallmark of  cancer. Over the years, a number of  critical 
proteins in DNA replication and repair have been shown to coordinate an FeS cluster (i.e. 
DNA2, DNA primase, Polα, Polδ, Polε, MUTYH, XPD, RTEL1, FANCJ, and ChlR1). 
These findings were rather surprising, given that upon FeS cluster oxidation, free iron 
atoms can generate dangerous reactive oxygen species that may interfere with DNA 
integrity and lead to genomic instability. So far, the function of  FeS clusters in these 
proteins is largely unknown. 
  Since all known FeS cluster proteins interact with MMS19/MIP18, core members 
of  the Cytoplasmic Iron-sulfur Assembly (CIA) machinery, we reasoned that new FeS 
proteins may be amongst the interaction partners of  MMS19/MIP18, previously identified 
by mass spectrometry. In this study we focused on Replication Factor C subunit 5 (RFC5) 
since it not only associates with MMS19/MIP18, but also displays synthetic lethality with 
mms19∆ in yeast, a feature observed for multiple FeS proteins. Using co-
immunoprecipitation interaction studies with the CIA machinery and 55Fe incorporation 
assays, our data show that while RFC5 interacts with both MMS19 and MIP18, it is unlikely 
to coordinate an FeS cluster. Additional studies will be required to identify the functional 
relevance of  RFC5’s interaction with the CIA machinery.  
  In our second study, we aimed to further characterize the role of  the FeS cluster 
in the nuclease/helicase Dna2, a known FeS cluster protein. The role of  the FeS cluster in 
Dna2 had been previously studied, where it was shown that loss of  the FeS cluster 
eliminated Dna2’s nuclease activity and reduced ATPase activity. Considering the fragile 
nature of  FeS clusters and the threat of  oxidation, coupled with advancements in protein 
purification and FeS cluster biology, we asked whether the integrity of  the FeS cluster was 
maintained during purification in the latter study. Therefore, using recombinant Dna2 WT 
and mutants purified using an optimized protocol, we characterized Dna2’s nuclease and 
helicase activities. Our in vitro data suggest that potent nuclease activity depends on the FeS 
cluster, but is not completely abolished in the FeS binding mutant, in contrast to previously 
reported data. Furthermore, the helicase activity is highly reduced upon loss of  the FeS 
cluster, despite the helicase domain being distant from the FeS binding domain. In 
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addition, we characterized the role of  Dna2’s FeS cluster in Okazaki fragment maturation 
with nuclease- and replication-based assays. Our data suggests that the FeS cluster in Dna2 
regulates its cleavage site in vitro, with WT Dna2 being able to cleave at the base of  an 
Okazaki fragment, while the FeS binding mutant is unable to cleave at the base, which 
prevents the formation of  a ligatable substrate and the completion of  Okazaki fragment 
maturation. Taken together, our data suggest a critical role of  the FeS cluster in Dna2 in 
regulating its cellular activities.  
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Zusammenfassung  
 Der genetische Bauplan aller lebender Organismen, ob unizellulär (z.B Bakterien) oder 
multizellulär (z.B der Mensch), ist in deren Genom codiert. Eine der grössten 
Herausforderungen einer Zelle ist es, ihr Genom zuverlässig zu verdoppeln und möglichst 
akkurat an ihre Tochterzellen weiterzugeben. Unterdessen sind Zellen im Laufe ihres 
Lebenszyklus häufig verschiedenen Formen von DNA-Replikationsstress und DNA-
Schäden ausgesetzt. Diese initiieren die Aktivierung eines komplexen Netzwerks aus 
Signalwegen, das kollektiv als DNA-Schadensantwort bezeichnet wird. Ein Scheitern dieses 
Prozesses kann zu genomischer Instabilität führen, die sich abhängig von den involvierten 
Mechanismen auf  verschiedene Art und Weise manifestieren kann und ein 
Schlüsselmerkmal von Krebserkrankungen darstellt. In den letzten Jahren wurde gezeigt, 
dass einige Proteine, die an der DNA-Replikation und -Reparatur beteiligt sind, ein Eisen-
Schwefel (FeS)-Cluster koordinieren (z.B. DNA2, DNA Primase, Polα, Polδ, Polε, 
MUTYH, XPD, RTEL1, FANCJ und ChlR1). Diese Erkenntnis war überraschend, da 
infolge einer Oxidation des FeS-Clusters freie Eisenatome gefährliche reaktive 
Sauerstoffspezies generieren, welche die DNA schädigen und so genomische Instabilität 
verursachen können. Bis heute ist die Funktion der FeS-Cluster in diesen Proteinen 
weitestgehend unbekannt. 
 Weil alle bekannten FeS-Cluster-Proteine mit MMS19/MIP18, den zentralen Mitgliedern 
der zytoplasmatischen Eisen-Schwefel-Cluster-Assembly (CIA) Maschinerie, interagieren, 
vermuteten wir, dass sich bisher unbekannte FeS-Cluster-Proteine unter den 
Interaktionspartnern von MMS19/MIP18 befinden, die zuvor mit Hilfe von 
Massenspektrometrie identifiziert wurden. In dieser Studie haben wir uns mit 
Replikationsfaktor C Untereinheit 5 (RFC5) beschäftigt, weil diese nicht nur mit MMS19/
MIP18 assoziiert, sondern zusätzlich in Hefe eine synthetische Letalität mit mms19∆ 
aufweist, eine Eigenschaft die bei mehreren FeS-Cluster-Proteinen beobachtet wurde. 
Durch Co-Immunpräzipitation mit der CIA-Maschinerie und 55Fe-Inkorporationsassays 
konnten wir zeigen, dass RFC5 zwar sowohl mit MMS19 als auch MIP18 interagiert, 
jedoch wahrscheinlich kein FeS-Cluster koordiniert. Zusätzliche Studien sind erforderlich, 
um die funktionale Relevanz der Interaktion zwischen RFC5 und der CIA-Maschinerie zu 
analysieren. 
 Unsere zweite Studie hatte das Ziel, die Rolle des FeS-Clusters in der Nuklease/Helikase 
Dna2, einem schon bekannten FeS-Cluster-Protein, zu charakterisieren. Die Rolle des FeS-
Clusters in Dna2 wurde zuvor in einer Studie untersucht, in der gezeigt wurde, dass der 
Verlust des FeS-Clusters Dna2’s Nukleaseaktivität eliminiert, sowie dessen ATPase-Aktivität 
reduziert. Die Fragilität des FeS-Clusters, das Risiko einer Oxidation, sowie den Fortschritt 
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bei Proteinaufreinigungsmethoden und der FeS-Cluster Biologie berücksichtigend, haben 
wir infrage gestellt, ob die Integrität des FeS-Clusters während der genannten Studie 
sichergestellt wurde. Deshalb haben wir die Nuklease- und Helikaseaktivität von 
rekombinantem Dna2, das mit Hilfe eines optimierten Protokolls aufgereinigt wurde, 
charakterisiert. Die Ergebnisse unserer in vitro Studien deuten darauf  hin, dass die 
Nukleaseaktivität vom FeS-Cluster abhängt, im Gegensatz zu den publizierten Daten 
jedoch in einer Mutante, die das FeS-Cluster nicht mehr binden kann, nicht komplett 
eliminiert wird. Des Weiteren ist auch die Helikaseaktivität nach Verlust des Clusters stark 
reduziert, obwohl die Helikase-Domäne weit entfernt von der Domäne liegt, die das FeS-
Cluster bindet. Zusätzlich haben wir die Rolle von Dna2’s FeS-Cluster bei der Okazaki-
Fragment-Reifung mit Nukleaseassays und Replikationsassays untersucht. Unsere Daten 
weisen darauf  hin, dass das FeS cluster in vitro die Schnittposition von Dna2 beeinflusst, 
wobei Wildtyp-Dna2 in der Lage ist, an der Basis eines Okazaki-Fragments zu schneiden, 
während die FeS-Bindemutante nicht an der Basis scheiden kann, was die Bildung eines 
ligierbaren Substrates und somit die Volllendung der Okazaki-Fragment-Reifung 
verhindert. Zusammenfassend zeigen unsere Daten, dass das FeS-Cluster eine wichtige 
Rolle bei der Regulation der zellulären Aktivitäten von Dna2 spielt. 
x
Acknowledgements  
  I would like to express my gratitude to Prof. Dr. Kerstin Gari for giving me the 
opportunity to work and study in her research group and involving me in such a exciting 
and fulfilling project. Furthermore, I would like to thank her for all of  her support in and 
out of  the lab, I have truly learned a lot from her and moving forward in life I will be able 
to take the skills she has taught me and apply them in whatever career I may find myself  in. 
Above all, I would like to thank her for her patience and understanding as I navigated 
through some difficult moments in life, it made hard times easier. 
  I would also like to thank the members of  my thesis committee: Prof. Dr. Josef  
Jiricny, Dr. Petr Cejka, Prof. Dr. Orlando Schärer, and Prof. Dr. Lorenza Penengo for all of  
the fruitful scientific discussions and support during the duration of  PhD studies.  
  Furthermore, I would like to thank the entire Institute of  Molecular Cancer 
Research, for creating a wonderful and stimulating working environment, it has been a 
pleasure to work alongside you these past years. In addition I would like to thank the 
technical and administrative staff, for taking care of  all us in the institute and for keeping 
everything moving so seamlessly, especially Farah Mhamedi, Odete Alves, Danielle 
Luterbacher, and Annica Mandola.  
  It goes without saying, but I want to give a huge thanks to all the members of  the 
Gari group, it has been a great privilege to work and grow scientifically with you. I am very 
grateful for your support and friendship and will always look back fondly on our time 
together. In addition, I would like to thank Dr. Maryna Levikova and Dr. Cosimo Pinto for 
all of  your assistance and guidance on the Dna2 project, it wouldn’t of  gotten off  the 
ground without your help. Moreover, I want to thank all of  my friends from back home 
and the new ones I’ve met in Europe, for your support and friendship, it truly means a lot.  
  I dedicate my thesis to my parents Ae Sun and Richard Lutz, thank you for all of  
the support through the years as I chased after my academic goals. I am very grateful to 
have parents that have always supported me, even when I left the continent. Furthermore, I 
would like to thank my sisters Kimberly and Jennifer for always being the best and 
supportive sisters in the world. In addition, I would like to thank Birgit and Frank Meyer 
for all of  their support as I moved, first to Germany and then to Switzerland, I am so 
grateful to have you in my life.  
  Last, but not least, I want to thank my partner Susanne Meyer, for always being 
there for me, supporting me and following me as I chased my academic goals. I wouldn’t be 
where I am today with out your steadfast support and love.  
xi

1. Introduction  
1.1 Genome Instability and Cancer  
  The genetic blueprint of  all living organisms, whether unicellular (e.g. bacteria) or 
multicellular (e.g. human) is encoded by its genome. One of  the most fundamental 
challenges of  the cell is to accurately copy and transmit its genome to daughter cells. 
Replicating the entire genome is no simple task; eukaryotic genomes are quite large, ranging 
from 107 to > 109 base pairs (bp), and are organized into multiple chromosomes. The basic 
machinery utilized during semi-conservative DNA replication is conserved from 
prokaryotes to eukaryotes, all working together in co-ordinated actions to promote 
replication fidelity. Moreover, the fidelity of  this process is dependent on the precision of  
regulatory mechanisms that couple DNA replication to cell cycle progression (DePamphilis 
et al., 2006).  
  During their life, cells are exposed to many forms of  DNA replication stress and 
DNA damage (Figure 1.1), and combat this via the complex network of  interconnected 
pathways, named the DNA damage response (DDR). If  this process goes awry, genomic 
instability develops and, depending on specific mechanisms involved, presents in various 
forms (Abbas et al., 2013). Therefore, genome instability can result from point mutations 
and microsatellite instability (MSI) that is characterized by the expansion or contraction of  
the number of  nucleotide repeats present in microsatellite sequences, and defective 
nucleotide or base excision repair (NER/BER), or mismatch repair (MMR). Additionally, 
genome instability may also result from gross chromosomal rearrangements, aneuploidy 
(i.e. the loss or gain of  copies in genes or chromosomal regions that differ from the wild 
type), hyper-recombination, loss of  heterozygosity (LOH) and, most commonly, 
chromosomal instability (CIN), which is in general defined by the elevated rates by which 
chromosome structure and number changes over time in cancer cells compared with 
normal cells (Abbas et al., 2013; Aguilera & García-Muse, 2013; Negrini et al., 2010).  
  The mechanisms underlying the causes of  these instabilities still remain elusive, 
but two major hypotheses attempt to explain the driving force of  tumor initiation and 
progression through genomic instability. The first, named the mutator hypothesis, 
establishes the idea that genomic instability present in pre-cancerous lesions is due to 
mutations in caretaker genes (i.e. DNA repair genes and mitotic checkpoint genes) and this 
helps them drive tumorigenesis by enhancing the accumulation of  spontaneous mutations 
(Loeb, 2011). In hereditary cancers, the presence of  genomic instability is clearly linked to 
mutations in DNA repair genes. Indeed, it was shown that germline mutations in breast 
cancer susceptibility type 1 (BRCA1), BRCA2, NBS1, Werner syndrome (WRN) helicase, 
BLM, and the Fanconi anemia genes, all involved in double-strand break (DSB) or DNA 
interstrand cross link repair, increase the risk for the development of  various cancers, such 
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as breast and ovarian cancer, leukemias and lymphomas as predicted by the mutator 
hypothesis (Negrini et al., 2010).  
Figure 1.1 Sources of  replication stress and DNA damage.  (A.) There are a number of  
conditions that can cause replication stress as noted above, some of  the key resolution pathways are 
indicated in bold. Figure modified from (Zeman & Cimprich, 2014) (B.) There are a variety of  DNA 
damaging agents (top), that induce a variety of  DNA lesions (middle), which are addressed by 
dedicated repair mechanisms (bottom). Any unresolved DNA damage may lead to cell death, and 
disease. Figure modified from (Hoeijmakers, 2001) 
A.
B.
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  In contrast to hereditary cancers, the molecular basis of  genomic instability in 
sporadic (non-hereditary) remains unclear. Although sporadic cancers exhibit genomic 
instability and mutations in a large number of  genes, they very often do not have mutations 
in the caretaker genes. The genomic instability exhibited in these cancers can be explained 
by the oncogene-induced DNA replication stress model (Halazonetis et al., 2008). In this 
model, tumor development results from oncogene-induced collapse of  DNA replication 
forks, especially at common fragile sites, followed by the formation of  DSBs and activation 
of  the DDR pathway. Breaks at common fragile sites can drive genomic instability and 
constitutively activated DDR also leads to elevated levels of  errors during DNA repair, 
which in turn favors the transition of  a precancerous lesion into cancer (Bartkova et al., 
2005; Gorgoulis et al., 2005; Yao & Dai, 2014). Furthermore, mutations in p53 and ATM, 
vital genes in cell cycle control and DNA repair, raise the support of  oncogene-induced 
DNA replication stress, as they cause gross misregulation of  DNA replication and repair. 
Therefore, mutations in p53 and ATM can be attributed to the development of  genomic 
instability and oncogene-induced DNA damage (Yao & Dai, 2014).   
  In spite of  the tremendous advances made in our understanding of  the causes of  
genomic instability and its role in the development of  cancer, more studies are required to 
clearly identify the mechanism of  tumor initiation. The hypotheses presented above may 
both be legitimate in specific settings, but regardless of  the driving force of  tumor 
initiation, the management of  DNA replication stress and DNA damage in a timely 
manner is critical, as they are major threats in maintaining genome integrity and stability 
and represent major hallmarks of  cancer (Figure 1.2)  (Abbas et al., 2013; Negrini et al., 
2010). 
Figure 1.2 The hallmarks of  cancer. First described by Douglas Hanahan and Robert Weinberg in 2000, 
details the multiple characteristics cells acquire in the development of  cancer. (Negrini et al., 2010) 
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1.2 Eukaryotic Cell Cycle  
  The most basic function of  the cell cycle is to accurately duplicate the entire 
genome and then segregate the copies into two genetically identical daughter cells. These 
activities define the two major phases of  the cell cycle, S phase (S for DNA synthesis) where 
chromosome duplication occurs and M phase (M for mitosis) where chromosome 
segregation and cell division occurs. In addition, the cell cycle contains two gap phases G1 
(between M- and S phase) and G2 (between S phase and mitosis) (Figure 1.3). During the 
gap phases, the cells monitor the internal and external environment to ensure all the 
conditions are met for the major processes of  S phase and mitosis. In the event that 
conditions are not met, cells can delay the progress of  G1 and enter a specialized resting 
state called G0 (Alberts et al., 2015, pp. 1054-1055). Furthermore, the cell cycle is highly 
regulated to ensure that all stages occur in the correct order and that each phase is 
completed before the next one commences (Sclafani & Holzen, 2007). If  the cell cycle’s 
regulatory mechanisms are compromised, this leads to the accumulation of  DNA damage 
or in some cases catastrophic damage that induces apoptosis, due to the misregulation of  
repair pathways. However, if  corrupted cells escape apoptosis, they may proliferate 
unchecked and replicate DNA without pausing to repair the damage, which contributes to 
genome instability and the development of  cancer (Alberts et al., 2015, p. 1074). 
Figure 1.3 Eukaryotic Cell Cycle  
Divided in discrete phases and progression 
regulated by cell cycle checkpoints, that help 
ensure the DNA is replicated faithfully and only 
once and that the cell is prepared for division. 
(Alberts et al., 2015)
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1.3 Eukaryotic DNA Replication  
  Eukaryotic DNA replication is a complex process that involves the coordination 
of  multiple protein complexes to initiate, synthesize and process the DNA (Burgers & 
Kunkel, 2017). The initial steps of  DNA replication occur as early as G1 phase of  the cell 
cycle, when pre-initiation replication complexes assemble at the origins of  replication. The 
origins of  replication are distributed throughout the genome and are strictly regulated to 
ensure a single firing per replication cycle. The origin recognition complex (ORC), a multi-
component complex, is then recruited to the origin. Next, Cdc6 recruits the 
minichromosome maintenance (MCM) proteins 2-7, joining the ORC to form the pre-
replicative complex (pre-RC). Pre-RCs are then activated to generate active replication 
forks (Masai et al., 2010). DNA synthesis always occurs in the 5’ to 3’ direction, but due to 
the anti-parallel nature of  DNA, moving replication forks can only synthesize one of  the 
two strands continuously. DNA synthesis in the direction of  DNA unwinding occurs 
continuously and is termed leading strand replication. In contrast, the other strand is 
synthesized discontinuously in small sections, which is termed lagging strand replication. 
Initiation of  DNA replication is associated with the formation of  the replicative CMG 
helicase (Cdc45, MCM 2-7, GINS) and the association of  the replicative polymerases (Table 
1.1) at the pre-RC (Burgers & Kunkel, 2017). In humans, Pol α/primase initiates de novo 
synthesis on both the leading and lagging strands by incorporating ~10 nucleotides (nt) of  
initiator RNA followed by ~20 nt of  initiator DNA (Burgers, 2009). Subsequently, the 
replication factor C (RFC) complex binds to the RNA/DNA primer and loads 
proliferating cell nuclear antigen (PCNA), which assists in the switching of  Pol α/primase 
for the more processive Pol δ  and/or Pol ε. Thereafter, elongation takes place on the 
leading strand via RFC, PCNA, and Pol ε, whereas, on the lagging strand, the small sections 
of  DNA, termed Okazaki fragments, are extended by RFC, PCNA, and Pol δ  (Garg & 
Burgers, 2005). However, the consensus view of  the division of  labor between Pol ε  and 
Pol δ on extending the leading and lagging strand has been challenged in recent years, with 
studies providing evidence that Pol δ functions as the main DNA polymerase in replication 
with Pol ε playing a more auxiliary role (Georgescu et al., 2014; Johnson et al., 2015).  
Table 1.1 Eukaryotic replicative DNA polymerases
DNA Polymerases Function 
α (alpha) Initiates DNA replication in conjunction with primase
δ (delta) Replication of  the lagging strand during S phase 
ε (epsilon) Replication of  the leading strand during S phase
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1.4 Lagging Strand Replication  
  As noted above, DNA replication can only occur continuously on the leading 
strand, which is elongated by Pol ε. In contrast, the lagging strand is synthesized in small 
sections (Okazaki fragments ~150-190 nt) by Pol δ. Upon encountering the previously-
synthesized Okazaki fragment, Pol δ displaces the downstream RNA/DNA primer into a 
5’ flap via strand displacement synthesis. This 5’ flap must be removed in order to create a 
ligatable nick that can be processed into a continuous DNA strand (Balakrishnan & 
Bambara, 2011). Failure to join the fragments compromises the integrity of  the genome.  
1.4.1 Lagging Strand Replication: FEN1 Only Pathway 
  Based on the available biochemical data, the nuclease thought to be responsible 
for digesting the majority of  the displaced flaps is Flap Endonuclease 1 (FEN1; Rad27 in 
S. cerevisiae). FEN1 is a 5’ to 3’ endonuclease that belongs to a class of  structure-specific 
flap nucleases that recognize and cleave at the 5’ junction between ssDNA and dsDNA to 
generate a nick (Balakrishnan & Bambara, 2013). The nick left by FEN1 is sealed by DNA 
ligase I, resulting in a mature Okazaki fragment that is part of  the continuous DNA 
complex (Figure 1.4). However, genetic studies have shown that the deletion of  FEN1 is 
still viable but the rad27∆ strain exhibits temperature-sensitive growth, defects in DNA 
replication, high rates of  recombination and methyl methanesulfonate (MMS) sensitivity 
(Reagan et al., 1995; Sommers et al., 1995). In addition, during the course of  strand 
displacement, the 5’ flaps can become longer and coated by the ssDNA binding protein, 
Replication Protein A (RPA). These longer RPA-coated 5’ flaps are unable to be processed 
by FEN1 (Bae et al., 2001). These findings questioned FEN1 as the sole nuclease involved 
in Okazaki fragment maturation, making it likely that overlapping pathways evolved to 
maintain such an essential process.   
1.4.2 Lagging Strand Replication: The Two Nuclease Pathway  
  The secondary pathway for Okazaki fragment processing was first proposed by 
Seo and colleagues, in which the longer 5’ RPA coated flaps require the action of  a second 
nuclease, Dna2. In this pathway, the binding of  RPA to the long flap intermediates inhibits 
FEN1, creating a requirement for Dna2, which is stimulated by RPA to cleave the flap. 
This generates a shorter flap (~5-7 nt) that can no longer be bound by RPA, freeing FEN1 
to generate a substrate for ligation (Bae et al., 2001) (Figure 1.4). Dna2 was originally 
discovered in a genetic screen for genes involved in DNA replication in yeast and was later 
shown to be involved in Okazaki fragment maturation via genetic and biochemical 
interactions with several known Okazaki fragment processing proteins (Budd & Campbell, 
1995; Budd & Campbell, 1997; Kuo et al., 1983). Furthermore, Dna2 was found to be an 
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essential gene with several temperature-sensitive mutants being identified to study the 
consequences of  impaired Dna2 activity. Two Dna2 mutants in particular have been well 
characterized; the dna2-1 (nuclease deficient) and dna2-2 (helicase deficient) strains (Budd & 
Campbell, 1995; Budd et al., 1995). As mentioned above, the rad27∆ strain is viable, but can 
not survive without Dna2 function, as dna2-1∆ and rad27∆ are synthetically lethal. In 
addition, it was shown that overexpression of  Dna2 suppresses the temperature-sensitive 
growth defects of  the rad27Δ strain, suggesting that Dna2  may compensate for the loss of  
function of  FEN1 in Okazaki fragment maturation (Budd & Campbell, 1997). These 
observations were later supported by in vitro experiments, which demonstrated that Dna2 
processes RNA-DNA flaps more efficiently than DNA-only flaps, making it well suited for 
the processing of  long flaps generated during Okazaki fragment maturation (Bae & Seo, 
2000). However, the observation that Dna2 would only degrade a portion of  the flap but 
not entirely, leaving behind a smaller flap (~5-7 nt), suggested that it functions in concert 
with FEN1 to produce a ligatable nick to complete Okazaki fragment maturation (Ayyagari 
et al., 2003; Bae et al., 2001). Interestingly, dna2-1∆ is lethal in combination with a mutation 
in Pol δ  (pol3-01) that stimulates strand displacement synthesis. In a similar fashion, 
deletion of  the Pol32 subunit, which limits strand displacement synthesis of  Pol δ in vitro, 
suppresses the growth defects of  the dna2-1∆ strain (Budd et al., 2005; Garg et al., 2004; 
Gerik et al., 1998; Johansson et al., 2004). Taken together, these observations suggest that 
Dna2 is critical under conditions that promote the formation of  long flaps and works in 
coordinated actions with FEN1 to produce a ligatable nick. This pathway for Okazaki 
fragment processing is now known as the “two-nuclease pathway”, however a recent study 
has challenged this notion, demonstrating that Dna2 can act as the sole nuclease in Okazaki 
fragment maturation in vitro, without the need for further FEN1 processing (Levikova & 
Cejka, 2015). In this study, Levikova and Cejka propose that Dna2  processes the majority 
of  Okazaki fragments, with FEN1 functioning downstream of  Dna2 in cases of  inaccurate 
cleavage by Dna2, or if  strand displacement synthesis occurs again before ligation can be 
completed. This hypothesis is further supported by the fact that Dna2 is essential in vivo, 
whereas FEN1 is dispensable under certain growth conditions.  
  Further work done in Saccharomyces cerevisiae demonstrated a genetic interaction 
between PIF1 and Dna2 (Budd et al., 2006). PIF1 is a 5’ to 3’ helicase involved in telomere 
maintenance and mitochondrial DNA replication. However, it was later shown that the 
selective inactivation of  the nuclear PIF1 isoform suppressed the lethality of  dna2Δ , 
pointing to a role for PIF1 in Okazaki fragment maturation by promoting long flap 
formation (Budd et al., 2006; Stith et al., 2008). Subsequent studies demonstrated in vitro 
that the PIF1 helicase directly stimulates the strand displacement synthesis activity of  Pol 
δ, indicating that DNA flaps are extended in the presence of  PIF1, which in turn makes 
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the function of  Dna2 required to complete Okazaki fragment maturation (Pike et al., 2009; 
Rossi et al., 2008).  
1.5 DNA Replication Stress 
  Remarkably, despite its size, the genome is duplicated faithfully during each cell 
cycle. However, DNA replication isn’t an unchallenged process. Deregulation of  internal 
cellular processes or exogenous sources that may interfere with replication can cause cells 
to undergo replication stress. Until now, due to a lack of  unambiguous markers that can be 
used to definitively detect this cellular event, replication stress remains insufficiently 
characterized. However, a defining characteristic of  replication stress is the slowing or 
stalling of  replication forks and/or DNA synthesis (Zeman & Cimprich, 2014).  There are 
a number of  conditions or replicative challenges that can slow or stall DNA replication, 
including reduced dNTPs pools, DNA lesions, ribonucleotide incorporation, repetitive 
DNA sequences, DNA-protein crosslinks, DNA secondary structures, fragile sites and 
oncogene-induced stress (Figure 1.1A) (Zeman & Cimprich, 2014). If  replication stress is 
not dealt with in a timely manner, it can lead to DNA damage that can exacerbate the 
stresses that challenge fork progression, provoking their collapse. In addition, several 
Figure 1.4 Two Models for Okazaki Fragment Maturation. During the course of  synthesis on the 
lagging strand, Pol δ encounters the terminal end of  the previous fragment and begins strand displacement 
synthesis. If  the displaced 5’ flap does not become too large and coated by RPA, it is processed solely by 
FEN1 (left side). However, in the event the 5’ flap becomes large and coated by RPA, the flap requires of  a 
second nuclease Dna2 (right side). First, Dna2 cuts along the flap leaving behind a smaller flap, that is then 
further processed by FEN1, completing Okazaki fragment maturation. In recent years, this model has been 
challenged by the observed ability of  Dna2 to cut at the base and its essential nature in cells. Figure 
Adapted from (Bae et al., 2001; Ayyagari et al., 2003) 
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studies have shown that pre-cancerous lesions display DNA damage, purportedly due to 
alterations of  the replication process (Técher et al., 2017).  
1.6 DNA Damage  
  DNA damage may result from both endogenous and exogenous challenges, for 
example, various environmental agents, such as ultraviolet (UV) light, ionizing radiation 
(IR) and genotoxic agents that can disrupt DNA integrity. Furthermore, normal metabolic 
processes, such as cellular respiration, can indirectly damage DNA through the production 
of  reactive oxygen species (ROS). Altogether, it is estimated that every cell experiences up 
to 105 DNA lesions per day (Hoeijmakers, 2001). However cells have evolved specific 
repair mechanisms to address the different DNA lesions inflicted on the cell (Figure 1.1B) 
(Hoeijmakers, 2009). The abundant causes of  replication stress and DNA damage highlight 
the challenges the cell faces during DNA replication. However, as noted above, under 
normal conditions there are multiple repair pathways dedicated to DNA damage signaling, 
repair and cell cycle control, that efficiently overcome these replicative obstacles (Ciccia & 
Elledge, 2010). 
1.7 DNA Damage Response (DDR)  
  To maintain genomic integrity, DNA must be safeguarded from damage induced 
by environmental agents and/or generated spontaneously during normal DNA 
metabolism. Therefore, to avoid the consequences of  DNA damage, cells have evolved a 
complex network of  interconnected pathways, named the DDR. The DDR is a 
multifaceted system that has the ability to sense DNA damage and, most importantly, 
transduce this information to influence the cellular response to it (Ciccia & Elledge, 2010). 
As noted in Figure 1.1B, there are a variety of  repair mechanisms for each specific form of  
damage. However, they are usually controlled by a common signaling program. 
Furthermore, the DDR is made up of  an arsenal of  strictly-regulated enzymatic tools, 
which cells use to remodel and repair DNA (Ciccia & Elledge, 2010). Errors occurring 
during the detection and repair process may lead to the introduction of  mutations in the 
genomic information. In general, any mutation may lead to detrimental effects, such as cell 
death and the acquisition of  various disorders including cancer (Salk et al., 2010). 
Therefore, it is unsurprising that genetic predisposition to mutations in DDR factors 
increase the overall rate of  mutations, which in turn increases genome instability, paving 
the way for the development of  cancer (Negrini et al., 2010).  
  The detection of  DNA damage leads to the activation of  one of  the three apical 
kinases, belonging to the family of  phosphatidylinositol 3-kinase-like protein kinases 
(PIKKs) (Shiloh, 2003). ATM (ataxia telangiectasia mutated) and DNA-PK (DNA-
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dependent protein kinase) become activated following detection of  DSBs by the Mre11-
Rad50-Nbs1 (MRN) complex or the Ku70-Ku80 heterodimer, respectively (Andegeko et 
al., 2001; Carson et al., 2003; Gottlieb & Jackson, 1993). The ATR (ataxia telangiectasia and 
Rad3-related) kinase is activated by ssDNA coated by RPA and requires the presence of  
the ATR-interacting protein (ATRIP), Rad17 and the 9-1-1 (Rad9, Rad1, Hus1) complex 
(Yang & Zou, 2006; Zou & Elledge, 2003). Furthermore,  proteomics analysis showed that 
DNA-PK activity is restricted to few proteins, whereas ATM and ATR target more than 
700 substrates, orchestrating the majority of  DDR events (Kotula et al., 2013; Matsuoka et 
al., 2007). Both ATM and ATR are activated by DNA damage and DNA replication stress, 
but they have distinct damage specificities and non-redundant functions. However, ATM 
and ATR often work in tandem to signal DNA damage and regulate a wide range of  
downstream cellular processes critical for genome stability, including DNA replication, 
DNA repair, and cell cycle control (Awasthi et al., 2015; Maréchal & Zou, 2013).  
1.8 Double-Strand Break Repair  
  As noted above, DNA damage may result from a variety of  different sources that 
inflict different DNA lesions, which are addressed by different and specific repair 
mechanisms (Figure 1.1B) (Hoeijmakers, 2009). Although occurring much less frequently 
than other DNA lesions, double-strand breaks (DSBs) are cytotoxic lesions formed when 
both strands of  the DNA duplex are broken. DSBs can form as a result of  endogenous 
metabolic reactions and replication stress or from exogenous sources like radiation and 
chemotherapeutics (Mehta & Haber, 2014). In addition, DSBs are essential intermediates 
during programmed recombination events, in particular meiosis, yeast mating-type 
interconversion and lymphocyte development (Symington & Gautier, 2011). However 
regardless of  their source, its been shown that defective DSB repair is associated with a 
number of  developmental, immunological and neurological disorders, and a major driver 
of  carcinogenesis (Chapman et al., 2012). Cells have evolved two mechanistically-distinct 
pathways to repair DSBs: non-homologous end joining (NHEJ) and homologous 
recombination (HR), with pathway selection being mostly influenced by the stage of  the 
cell cycle (Abbas et al., 2013). 
1.8.1 Non-homologous End Joining  
  As the name implies, NHEJ involves the direct ligation of  the broken ends and 
represents the simplest mechanism to repair DSBs and restore chromosome integrity 
(Symington & Gautier, 2011). Although NHEJ can operate during all phases of  the cell 
cycle, its function is critical in the G1 phase, where the initial step in HR, the 5’ to 3’ 
resection of  DSB ends is blocked. In addition, G1 cells lack the homologous sister 
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chromatid, which is used as a template to repair the DSB via HR (Mehta & Haber, 2014). 
Due to the direct ligation of  the broken ends, NHEJ is considered an error-prone process, 
that often results in small insertions, deletions, substitutions at the break site, and 
translocations if  DSBs from different parts of  the genome are joined together (Chapman 
et al., 2012).    
  NHEJ is initiated when the two DSB ends are recognized and bound by the 
Ku70/Ku80 (Ku) heterodimer. The Ku heterodimer serves as a scaffold to recruit the 
other NHEJ factors to the site of  the damage, including the DNA-dependent protein 
kinase catalytic subunit (DNA-PKcs), X-ray cross complementing protein 4 (XRCC4), 
DNA Ligase IV, and XRCC4-like factor (XLF) (Davis & Chen, 2013). Together, these 
proteins work in a sequential order to (i) recognize a DSB and protect it from degradation, 
(ii) process non-ligatable ends, and (iii) stimulate and complete end joining (Figure 1.5 )
(Iyama & Wilson III, 2013). Despite being an error-prone process, NHEJ is critical in 
maintaining genome stability. Indeed, it has been shown that loss of  NHEJ factors leads to 
an increase in chromosomal aberrations and non-reciprocal translocations (Davis & Chen, 
2013) 
Figure 1.5 DSB Repair: HR & NHEJ. DSB repair is divided into two major pathways: HR & NHEJ. 
Repair pathway choice is in one part dependent on the phase of  the cell cycle. HR is initiated by 
recognition of  the DSB by MRN and the initial end resection. Further resection is carried out by EXO1 
and/or DNA2/BLM, which generates a long 3’ strand overhang that is rapidly coated by RPA. RAD52 
assists RAD51 along with mediator protein BRCA2, in replacing RPA with RAD51 to form a 
nucleoprotein filament. In SSA, recombination is RAD51 independent. Next, the RAD51 nucleoprotein 
filament promotes homology search and invasion, which generates a D-loop, that can be resolved in 
pathways that result in Co and NCO products, via normal DSBR or SDSA.  Figure modified from 
(Iyama & Wilson III, 2013) 
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1.8.2 Homologous Recombination  
  DNA DSBs can be repaired by several varying HR pathways. Single-strand 
annealing (SSA) is the most basic HR mechanism, which involves the annealing of  
homologous repeat sequences that flank a DSB, which causes a deletion rearrangement 
between the repeats (Bhargava et al., 2016). However in general, HR depends on the 
recognition and pairing of  broken DNA ends with intact homologous sequences on a 
sister chromatid or, less commonly, the homologous chromosome and is largely considered 
an error-free process (Mehta & Haber, 2014). In contrast to NHEJ which can operate 
throughout the cell cycle, HR is generally restricted to the S- and G2 phase following DNA 
replication, mainly due to the availability of  the sister chromatid (Chapman et al., 2012).  
  HR is initiated when the DSB is recognized by the MRN (MRE11, RAD50, and 
Nijmegen breakage syndrome 1 (NBS1)) complex. Next, the MRN complex associates with 
the C-terminal binding protein (CtBP)-interacting protein (CtIP). Together, they perform 
the initial 5’ to 3’ end resection, generating the required 3’ ssDNA overhang for strand 
exchange. As noted above, NHEJ is active during all phases of  the cell cycle, so during S- 
and G2 phase NHEJ and HR factors “compete” for substrates. The MRN-dependent 
DNA resection acts as a control point and commits the cell to repair the DSB via HR (Jasin 
& Rothstein, 2013). Next, the 3’ overhang is further processed by either Exonuclease 1 
(EXO1), which cleaves mononucleotides, or DNA2 in conjunction with the Bloom 
syndrome (BLM) helicase, that cleaves off  short oligonucleotides from the 5’ strand (Cejka 
et al., 2010; Huertas et al., 2008; Mimitou & Symington, 2008; Zhu et al., 2008). 
Immediately following the end resection, the ssDNA tails are bound by RPA to remove 
disruptive secondary structures and prevent degradation. This activates ATR via an 
interaction with ATR-interacting protein (ATRIP) that signals the full checkpoint response 
(Iyama & Wilson III, 2013). In turn, RAD52 is recruited and promotes replacement of  
RPA with the RAD51 recombinase. Along with mediator protein Breast cancer type 2 
susceptibility protein (BRCA2), RAD51 replaces RPA and forms a nucleoprotein filament 
on the ssDNA strand. Once the RAD51 nucleoprotein filament is formed, it promotes 
homology search and strand invasion on the intact homologous DNA region, providing 
the genetic instructions for error-free repair (Mehta & Haber, 2014). Here, RAD51 
facilitates the contact between the invading ssDNA and the homologous DNA duplex in a 
so-called displacement loop (D-loop) (Krejci et al., 2012). Next, repair synthesis is 
performed, where the invading 3’ strand acts as a primer, while the donor duplex acts as 
the template. The required DNA polymerase remains elusive in vivo, but the extension is 
most likely mediated by DNA Pol η  (eta) or Pol δ  (McVey et al., 2016). There are two 
predominant models that have been proposed for D-loop resolution, of  which 
endonucleolytic cleavage can lead to crossover (CO) and/or non-crossover (NCO) 
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products. The first model involves the formation of  a double 4-way junction intermediate 
structure known as a double Holliday junction (dHJ). In this model, dHJs are resolved in 
one of  three ways: (i) symmetrical cleavage by the endonucleases GEN1, Slx1/Slx4, (ii) 
asymmetric cleavage by endonuclease Mus81/Eme1, which leads to CO products 
(Schwartz & Heyer, 2011) or, (iii) dissolution of  the HJ to generate exclusively NCO 
products. This is mediated by the BLM helicase, topoisomerase III α  and the RMI1-2 
complex, which work in tandem to permit branch migration and decatenation of  the linked 
strands of  the two HJs (Bizard & Hickson, 2014). In the second model, designated the 
synthesis-dependent strand annealing (SDSA) pathway, DSB repair is completed via NCO 
products without Holliday junction formation. In SDSA, the newly-synthesized strand is 
displaced and re-annealed to the second DNA end (Figure 1.5) (Jasin & Rothstein, 2013).  
1.9 Iron-Sulfur (FeS) Cluster Proteins  
  Iron-Sulfur (FeS) clusters are ancient inorganic cofactors, remnants of  an 
anaerobic world. FeS clusters present a particular problem in an aerobic world, because FeS 
cluster proteins are particularly sensitive to oxidation, which frequently leads to the 
destruction of  the cluster and the subsequent inactivation of  the protein. Despite this, cells 
have gone through a lot of  effort to maintain them, and they are required to sustain 
fundamental life processes (Imlay, 2006). FeS cluster proteins are involved in cellular 
processes as diverse as DNA replication and repair, RNA modification, gene regulation, 
electron carriers in redox reactions, regulatory sensors, protein stability and iron 
metabolism (Barras, 2017). The biogenesis of  eukaryotic FeS cluster proteins is mediated 
by the mitochondrial iron-sulfur cluster assembly (ISC) and the cytosolic FeS protein 
assembly (CIA) machineries. Both the ISC and CIA machineries are specifically involved in 
cytosolic and nuclear FeS protein maturation, whereas the ISC machinery alone is required 
for the maturation of  all other cellular FeS proteins (Lill & Mühlenhoff, 2008). 
1.9.1 Structure of  FeS Clusters  
  The most common and simplest FeS clusters are of  the rhombic [2Fe-2S] and 
cubic [4Fe-4S] types (Figure 1.6) (Rees & Howard, 2003). Furthermore, in several FeS 
proteins, one iron of  a [4Fe-4S] cluster may be lost to form a [3Fe-3S] cluster, or undergo 
metal substitutions to generate mixed-metal clusters (Lill & Mühlenhoff, 2008). [4Fe-4S] 
clusters can alter their oxidation states between +2 and +3, due to the fact that iron exists 
as Fe2+ or Fe3+, while sulfur always exists in the -2 oxidation state (S2-). FeS clusters are 
typically coordinated in proteins by four conserved cysteine-sulfur residues, however, 
coordination with nitrogen atoms of  histidine and arginine, serine residues or small 
molecules (e.g. CN-, homocitrate) has been observed (Rees, 2002). Another important 
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aspect of  FeS clusters are their versatile electrochemical properties with redox potentials 
ranging from +300 mV to -500 mV, which makes them excellent electron donors/
acceptors. Furthermore, the binding motifs for FeS cluster proteins are not highly 
conserved and can differ radically. However, some consensus motifs have been described in 
some mammalian and plant ferredoxins, but an ubiquitous FeS binding motif  has yet to be 
identified (Lill & Mühlenhoff, 2008). 
1.9.2 Iron-Sulfur Cluster Proteins Involved in DNA Repair and Replication 
  The most common function for FeS cluster proteins is in electron transfer during 
cellular respiration. However, a growing number of  proteins involved in DNA replication 
and repair have been shown to bind an FeS cluster (i.e. DNA2, Primase, Pol α, Pol ε, Pol δ, 
MutYH, XPD, RTEL1, FANCJ, and ChlR1) (Netz et al., 2012; Wu & Brosh, 2012) (Table 
1.2). These findings were rather surprising, given that upon FeS cluster oxidation, free iron 
atoms can generate dangerous ROS that may interfere with DNA integrity and lead to 
genomic instability. Moreover, the FeS cluster is predicted to be crucial for the protein 
functions, but its precise molecular role is largely unknown (Paul & Lill, 2015).  
1.9.3 Potential Roles of  the FeS Cluster in Genome Maintenance Proteins  
  Despite the inherent danger to oxidation and degradation, FeS clusters are crucial 
for the function of  proteins involved in DNA replication and repair activities. For the 
majority of  these genome maintenance proteins, their FeS cluster has been thought to play 
a non-catalytic role in stabilizing the structure of  the protein (White & Dillingham, 2012). 
However, a model proposed by the Barton group suggests that the redox-active FeS 
clusters of  DNA glycosylases are used to scan the genome for DNA damage (Boal et al., 
2007; Boal et al., 2009). Their model is based on the fact that electron transport can occur 
over long molecular distances within the DNA duplex due to π-stacking (Kelley & Barton, 
1999; Núñez et al., 1999) and that the presence of  damage or mismatched bases causes a 
Figure 1.6 Basic FeS Clusters. Schematic representations of  the basic types of  FeS clusters containing 
one to four iron atoms. Figure modified from (Rees, 2002)
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significant disruption in electron transport within the duplex (Boon et al., 2000). This 
model therefore, proposes that through DNA-mediated charge transfer, genome 
maintenance proteins use their FeS clusters to scan DNA and distinguish between intact 
and damaged DNA (Boal et al., 2005). However, not all FeS proteins are involved in 
damage detection, it is therefore likely that the FeS cluster in other proteins may be utilized 
in different ways. Indeed, recent studies have shown a critical role of  the FeS cluster in 
DNA polymerases in the formation of  active replicative complexes and in DNA primase as 
an on/off  switch for DNA binding and efficient RNA primer synthesis (Netz et al., 2012; 
O’Brien et al., 2017).  
1.9.4 Conserved Family of  FeS Cluster Binding Helicases Linked to Human Disease 
  XPD (Rad3 in S. cerevisiae) is the founding member of  a superfamily 2 (SF2) of  
helicases that includes RTEL1, FANCJ, and ChlR1. Key characteristic of  all family 
members is binding of  an FeS cluster via four conserved cysteine residues and 5’ to 3’ 
helicase activity (White, 2009). Furthermore, all family members are linked to human 
diseases (Table 1.2).  XPD is part of  the transcription initiation factor (TFIIH) complex that 
plays a critical role in basal transcription and NER. Mutations within XPD have been 
linked to three genetic disorders, namely xeroderma pigmentosum (XP), Cockayne 
syndrome (CS) and Trichothiodystrophy (TTD). These diseases are all characterized by skin 
hypersensitivity to sun exposure, a result of  defective NER (Lehmann, 2003). Interestingly, 
a common point mutation in TTD patients (arginine to histidine; R211H) which lies just 
outside of  the FeS cluster binding domain, exhibits abolished helicase activity and is unable 
to stably bind an FeS cluster (Rudolf  et al., 2006). RTEL1 is an essential anti-recombinase 
that is required for limiting meiotic recombination, removing toxic recombination 
intermediates and regulating telomere integrity (Vannier et al., 2014). Single-nucleotide 
polymorphism (SNPs) variants in RTEL1 have been shown to increase susceptibility to 
high-grade glioma and mutations within RTEL1 have been identified in individual patients 
with Hoyeraal-Hreidarsson syndrome, a severe variant of  dyskeratosis congenita (DC), 
characterized by early onset bone marrow failure, immunodeficiency and developmental 
defects, due to dysfunctional telomeres (Le Guen et al., 2013; Wrensch et al., 2009). FANCJ 
was identified as the gene mutated in the J complementation group of  Fanconi anemia 
(FA), a genome instability disorder with elevated risk of  cancer development that functions 
in DSB repair and interstrand crosslink repair (Paul & Lill, 2015). One FANCJ point 
mutation commonly found in FA patients (alanine to proline; A349P), located immediately 
adjacent to one of  the conserved cysteine residues of  the FeS binding domain, exhibits 
abolished FeS cluster binding and defects in helicase activity and displacing DNA-bound 
proteins (Wu et al., 2010). DDX11 (ChlR1) mutations are associated with the rare genetic 
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disorder Warsaw breakage syndrome (WABS), characterized by congenital abnormalities 
and - on a cellular level - defects in sister chromatid cohesion (van der Lelij et al., 2010). 
Interestingly, the WABS patient point mutation (arginine to Glutamine; R263Q), which is 
also located just outside of  the FeS binding domain, abolishes helicase activity and DNA-
dependent ATP hydrolysis (Capo-Chichi et al., 2013). Taken together, these findings 
illuminate the essential role the FeS cluster plays in this SF2  helicase family and genome 
stability.  
Table 1.2 FeS cluster binding DNA repair and replication proteins
Human DNA metabolism FeS cluster binding proteins and their yeast counterparts, and associated disease. Table 
modified from ( Paul & Lill, 2015)
Human Yeast Function Associated Disease 
CHLR1 Chl1 Helicase, sister chromatid cohesion, heterochromatin 
organization 
Warsaw breakage 
syndrome
DNA2 Dna2 Helicase/nuclease, DNA repair, Okazaki fragment 
maturation, telomere maintenance 
FANCJ - Helicase, DNA interstrand crosslink repair Fanconi Anemia 
MutYH - DNA glycosylase, base excision repair 
Pol α Pol α DNA replication
Pol δ Pol δ DNA replication 
Pol ε Pol ε DNA replication 
Primase Primase DNA replication and DSB repair
RTEL1 - Helicase, regulation of  telomere length, anti-recombinase Hoyeraal-
Hreidarsson 
syndrome, high-
grade glioma
XPD Rad3 Helicase, nucleotide excision repair Xeroderma 
pigmentosum, 
Cockayne 
syndrome, 
Trichothiodystrophy 
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1.9.5 Biogenesis of  FeS cluster proteins  
  As noted above, the biogenesis of  all cytosolic and nuclear FeS cluster proteins 
requires the assistance of  both the ISC and CIA machineries (Lill, 2009). In general, FeS 
cluster biogenesis can be divided into two main steps, (i) the de novo assembly and transient 
binding of  an FeS cluster on the CIA scaffold complex, and (ii) the transfer of  the FeS 
cluster from the scaffold to target apoproteins (Lill, 2009). In the first step, in conjunction 
with the mitochondrial ISC machinery, an unknown sulfur-containing compound (X-S) is 
generated and transferred to the cytosol by the ABC7 transporter protein, where it is 
transported to the CIA scaffold complex made up of  NTPases (CFD1/NBP35) (Netz et 
al., 2007). Next, at the CIA scaffold complex, an unknown iron donor is taken up and is 
assembled into an FeS cluster in the cytosol, which is supported by the lack of  evidence of  
intact FeS clusters crossing the inner mitochondrial membrane (Rouault, 2015). Once 
assembled, the FeS cluster is transferred to the CIA targeting complex, which is made up 
of  MMS19 nucleotide excision repair protein homolog (MMS19), MIP18 family protein 
FAM96B (MIP18) and cytosolic iron-sulfur assembly component 1 (CIAO1), and iron-only 
hydrogenase like protein (IOP1) (Paul & Lill, 2015). The core CIA members MMS19, 
MIP18 and CIAO1 mediate the insertion of  the FeS cluster into apoproteins, producing 
the mature holoprotein (Figure 1.7) (Netz et al., 2013). In addition, IOP1 has also been 
shown to be essential to this process, but was suggested to act outside of  the core CIA 
members, but possibly acts to connect the early- and late-acting components of  the CIA 
machinery via an unknown mechanism (Paul & Lill, 2015; Seki et al., 2013).   
Figure 1.7 Cytosolic and Nuclear FeS cluster Protein Biogenesis via CIA . Cytosolic and Nuclear 
FeS cluster protein maturation occurs in the cytoplasm. (i) via ISC machinery in the mitochondria, a 
sulfur donor is released to the cytoplasm where it meets an unknown Fe donor and (ii) on the CIA 
scaffold complex the FeS cluster is assembled. In the last step, (iii) the FeS cluster is transferred to the 
CIA targeting complex, where through the specific actions of  MMS19, MIP18, and CIAO1 the FeS 
cluster is inserted into the apoproteins. 
MMS19
CIAO1
IOP1
MIP18
FeS 
apo
FeS 
holo
CFD1 NBP35
NBP35 CFD1
Scaffold complex Targeting Complex
X-S
ABC7
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1.9.6 Iron-Sulfur Cluster Biogenesis and the Link with Genome Stability  
  The maturation of  these FeS cluster binding DNA metabolizing proteins requires 
both the ISC and CIA assembly machineries. Both genetic and biochemical studies have 
shown that all stages of  FeS cluster biogenesis are intimately linked with the maintenance 
of  genome stability. Namely, defects in FeS cluster biogenesis factors prevents the 
upstream maturation of  critical proteins in DNA repair and replication, leading to genomic 
instability (Paul & Lill, 2015). Since the identification of  MMS19 as a component of  the 
CIA targeting complex, functional studies have shown that MMS19 depletion in both yeast 
and human cells causes sensitivity to hydroxyurea, S-phase defects during the cell cycle and 
inhibits XPD incorporation into the transcription factor IIH (TFIIH) complex, which is 
required for transcription and nucleotide excision repair (Gari et al., 2012; Paul & Lill, 
2015; Stehling et al., 2012; Zhang, 2014). Furthermore, MMS19 has also been shown to 
interact directly with all known nuclear FeS cluster proteins, linking it to various DNA 
metabolic pathways and, in an indirect way, making it an essential component in 
maintaining genome stability (Paul & Lill, 2015). 
1.10 Identifying and Characterizing Novel Nuclear Iron-Sulfur Cluster Proteins  
  To date, there are no defined motifs for FeS cluster binding; in fact most FeS 
cluster proteins were discovered by chance. This is in part due to the fact that essential 
factors of  the FeS cluster biogenesis pathways have only been recently discovered and 
characterized. Furthermore, the discovery of  these factors via genetic screens was not 
possible due to their necessity for cell survival (Dos Santos & Dean, 2017). However, two 
independent studies showed that MMS19 is a crucial member in the CIA targeting 
complex, and that interaction with MMS19 is a critical step in FeS cluster biogenesis for all 
FeS cluster proteins involved in DNA repair and replication (Gari et al., 2012; Stehling et 
al., 2012). In addition, later studies identified MIP18 as a CIA targeting complex member, 
and it was shown to bind to both CIA targeting complex members and FeS proteins, and 
specifically binds to the FeS cluster coordinating regions in FeS proteins (Stehling et al., 
2012; van Wietmarschen et al., 2012). Taken together, these findings show that CIA 
targeting complex members play a central role in FeS cluster insertion into FeS apoproteins. 
These new discoveries opened up the possibility of  identifying novel nuclear FeS cluster 
proteins via their interaction with MMS19/MIP18. In addition, novel FeS cluster proteins 
may be identified via the observed synthetic lethality of  yeast mms19∆ with the deletion of  
multiple FeS proteins (e.g. Polδ) (Collins et al., 2007). 
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1.11 Aim of  Studies: Identifying and Characterizing Novel and Known Nuclear FeS Cluster Proteins  
  As summarized above, a growing number of  essential proteins involved in DNA 
repair and replication have been shown to bind an FeS cluster and in some cases are linked 
to human disease (Table 1.2). Due to the identification of  crucial CIA members (i.e. 
MMS19 & MIP18), we reasoned that it may be possible to identify potential unknown FeS 
cluster proteins via interactome analysis. Previously, FeS proteins were discovered 
serendipitously. Through the duration of  my doctoral studies, we set out to confirm 
whether our candidate protein, RFC5 (see 1.10) is a bona fide nuclear FeS cluster protein and 
characterize the function(s) it may play in its cellular activities. In our second aim, we 
investigate the role the FeS cluster plays in the nuclease/helicase Dna2 (See 1.11), a known 
FeS cluster binding protein involved in both DNA repair and replication. Considering the 
crucial role that many of  these proteins play in DNA repair and replication, we aim to 
characterize the role of  the FeS cluster in known proteins, in order to elucidate its precise 
molecular function. It is clear that the FeS cluster likely plays a role in protein stability, but 
other, more intricate, biochemical functions are expected, such as redox sensing of  DNA 
damage (Paul & Lill, 2015). Together, these studies will allow us to paint a clearer picture of  
the role(s) FeS cluster proteins have on global genomic stability. 
1.12 Aim 1: Identifying Potential Novel Nuclear FeS Cluster Proteins: RFC5 
  The 36 kDa RFC5 subunit, consisting of  340 amino acids, was found to bind to 
MMS19 by mass spectrometry (Stehling et al., 2012). Further, deletion of  Rfc3, the yeast 
counterpart to RFC5, was found to be synthetic lethal with mms19∆ (Collins et al., 2007). 
RFC5 is part of  an evolutionarily-conserved AAA+ ATPase (ATPases Associated with 
diverse cellular Activities family) protein complex that is composed of  five distinct subunits 
(RFC1-5) (Figure 1.8). Like all of  the other RFC subunits, RFC5 possesses several 
conserved domains: AAA+ ATPase domain containing Walker A, Walker B, Sensor I, 
Sensor II motifs and the trans-acting arginine finger, and an RFC C-terminal domain. The 
Replication Factor C complex (RFC), the eukaryotic clamp loader, is highly-conserved 
from yeast to human (Hedglin et al., 2013). The clamp tethers DNA polymerases to DNA 
to increase the processivity of  synthesis, as well as the efficiency of  replication (Thompson 
et al., 2012).  
  As noted above, RFC’s canonical function couples the energy from ATP binding 
and hydrolysis to the loading of  the DNA replication processivity clamp protein, PCNA, 
onto DNA (Johnson et al., 2006). Additionally, the alternative RFC complexes and their 
functions have begun to be unraveled. It has been shown that CTF18-RFC acts in cohesion 
establishment and replication checkpoint activation (Skibbens, 2005). The RAD17-RFC 
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(Rad24 in S. cerevisiae) complex has been shown to act on the PCNA-like 9-1-1 complex 
(RAD9-RAD1-HUS1; Rad17-Mec3- Ddc1 in S. cerevisiae) placing it at sites of  DNA 
damage (Bermudez et al., 2003). Lastly, the ATAD5-RFC (Elg1 in S. cerevisiae) complex has 
been recently shown to act in unloading PCNA during DNA replication, preventing the 
accumulation of  PCNA on chromatin, which if  left bound could lead to genomic 
instability (Kubota et al., 2013; Lee et al., 2013).
It has been widely assumed that the sole determinant of  specificity and function 
of  the RFC complexes was the large subunit. Although each complex differs only in the 
large subunit, recent studies have shown that the smaller subunits (RFC2-5) also play a role 
in specificity and that the ATP sites work in unison to promote the conformational 
changes in the clamp-loading reaction (Marzahn et al., 2014). Moreover, these studies 
suggest that the smaller subunits may play a larger role in the function of  the holocomplex 
and that each subunit could possibly have a unique function in the clamp-loading reaction 
(Daee & Myung, 2010). Therefore, we hypothesized that an FeS cluster in RFC5 could 
potentially play a role in its DNA-related activities, complex formation and regulation of  
alternative-RFC complexes.  
1.13 Aim 2: Elucidating the Role of  the Iron-Sulfur Cluster in the Nuclease/Helicase Dna2   
  In our second aim, we investigate the role of  the FeS cluster in DNA replication 
ATP-dependent nuclease/helicase DNA2 (Dna2). As noted above, Dna2 is an essential 
protein that was found to be required for DNA replication in vivo. The Saccharomyces cerevisiae 
Dna2 has a size of  172 kDa and contains an unstructured N-terminal regulatory domain, a 
RecB family nuclease domain and a superfamily I (SF1) helicase domain (Figure 1.9). Four 
cysteine residues (a.a. 516, 768, 771, 777) located within the nuclease domain coordinate an 
RFC1 (Rfc1)
RFC2 (Rfc4)
RFC5 (Rfc3)
RFC3 (Rfc5)
RFC4 (Rfc2)
Figure 1.8 Structure of  the RFC Complex. Basic structure of  the RFC complex with yeast counterparts 
in parentheses. RFC1, represents the largest subunit and is thought to be the determinant in RFC function 
between the other alternative complexes. RFC5 along with RFC2 and RFC4, make up a central “core” of  
the complex. Figure modified from (Hedglin et al., 2013)
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FeS cluster that is thought to play a role in protein stabilization. Dna2 is highly conserved, 
present in eukaryotes from yeast to human; however, the N-terminal regulatory domain is 
very poorly conserved (Wanrooij & Burgers, 2015). In addition, Dna2 belongs to a novel 
class of  proteins with a nuclease domain and a conserved FeS cluster that includes the 
bacterial AddAB nuclease/helicase (Yeeles et al., 2009). 
1.13.1 Cellular Roles of  Dna2  
  Dna2 is a multifunctional protein that possesses both nuclease and helicase 
activities that require a free unblocked ssDNA end for loading (Bae & Seo, 2000; Bae et al., 
1998; Balakrishnan et al., 2010). Dna2 contains ssDNA-specific endonuclease, 5’ to 3’ 
helicase and DNA-dependent ATPase activities. The nuclease activity can be either 5’ to 3’ 
or 3’ to 5’, where RPA stimulates the former and inhibits the latter (Cejka et al., 2010; Lee 
et al., 2000; Wanrooij & Burgers, 2015). The helicase activity of  Dna2 has been considered 
weak, mostly owing to the fact that its nuclease activity auto-inhibits its helicase. However, 
it was recently shown that Dna2 possesses potent helicase activity in a nuclease-dead 
background (Levikova et al., 2013). Even so, studies of  separation-of-function mutants 
have shown that the nuclease activity of  Dna2 is essential for cell survival, whereas 
helicase-dead mutants are viable. That being said, helicase-dead mutants exhibit growth 
defects, sensitivity to methyl methanesulfonate (MMS) and IR, which indicates the helicase 
activity still contributes to Dna2 function in vivo (Budd & Campbell, 2000; Budd et al., 
1995, 2000; Formosa & Nittis, 1999). Dna2 preferentially binds to and acts on 5’-flap 
structures, binding to the 5’-flap, threading over its 5’ end and moving down the flap in 
order to cleave its substrate, leaving 3-4 nt from the base of  the flap (Balakrishnan et al., 
2010; Stewart et al., 2010). As noted above, Dna2 has various essential cellular roles, such 
as Okazaki fragment processing, repair of  DSBs in conjunction with BLM helicase (Sgs1 in 
S. cerevisiae), telomere maintenance, prevention of  replication fork reversal and checkpoint 
activation (Figure 1.10) (Wanrooij & Burgers, 2015).  
Figure 1.9 Structure of  Yeast and Human Dna2/DNA2. Dna2 is highly conserved from yeast to 
humans, apart from the N-terminal domain which is absent higher eukaryotes. Key features: RecB family 
nuclease domain, SF1 helicase domain, and FeS cluster coordinated within the nuclease domain. Figure 
modified from (Wanrooij & Burgers, 2015).
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1.13.2 The FeS cluster in Dna2  
  As noted above, Dna2 is part of  a novel class of  proteins that have a nuclease 
domain and conserved FeS cluster. Dna2 was first identified as a potential member of  this 
family, when sequence comparison with the AddAB nuclease/helicase revealed a potential 
FeS binding domain within its nuclease domain (Yeeles et al., 2009). Later, a study by 
Pokharel and Campbell, confirmed yeast Dna2 as a bona fide FeS cluster protein. 
Furthermore, their biochemical analysis revealed that loss of  the FeS cluster is detrimental 
to its nuclease activity but, in contrast to AddAB, did not affect DNA binding and protein 
structure, as indicated by limited protease digestion experiments. Interestingly, the loss of  
the FeS cluster also reduced its ATPase activity, even though the ATPase domain is located 
in the C-terminal helicase domain (Pokharel & Campbell, 2012) .  
  Considering the fragile nature of  FeS clusters and the threat of  oxidation, coupled 
with advancements in protein purification and FeS cluster biology, we asked whether the 
integrity of  the FeS cluster was maintained during purification in earlier studies. For 
example, in a recent study, Dna2 purified from an optimized protocol, was shown to be 
more active and able to function as the sole nuclease during Okazaki fragment processing, 
challenging the accepted “two nuclease” model (Levikova & Cejka, 2015). These data 
suggest, that Dna2 can cut at or near the base, acting as the sole nuclease in Okazaki 
fragment maturation and that Fen1 may only function in a specific subset of  fragment 
processing. Moreover, Dna2’s helicase activity was considered to be weak due to the auto-
inhibitory effects of  the nuclease activity. However, in a nuclease-deficient background, 
Dna2 exhibits potent helicase activity (Levikova et al., 2013). Therefore, it is tempting to 
speculate whether the redox state of  the FeS cluster plays a role in regulating nuclease/
helicase activity. Taking into account Dna2’s various cellular roles, we hypothesized that 
perhaps the FeS cluster in Dna2 may be responsible for regulating the balance between its 
activities in vivo. Therefore, we set out to address whether the FeS cluster plays a larger role 
Figure 1.10 Dna2 at the nexus of  DNA replication and repair Left Panel: Dna2 acts during DNA 
lagging strand replication, processing Okazaki fragments in conjunction with Fen1 generating cleavable 
nicks. Middle Panel: Dna2 works in conjunction with Sgs1/BLM in a DSB end resection pathway. Right Panel: 
Dna2 prevents replication fork reversal   Figure modified from (Wanrooij & Burgers, 2015). 
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in regulating Dna2’s cellular activities and structural stability, as mutations to its FeS binding 
domain are not likely to be tolerated.  
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2. Materials and Methods  
2.1 General Buffers, Solutions, and Media  
LB Medium Yeast-extract 10g/l  
Tryptone 10g/l 
NaCl 10g/l  
LB medium according to Miller; pH adjusted to 7.5 and autoclaved 
LB Agar LB medium 
agar (2% wt/vol)
Yeast Medium 1x Standard synthetic medium (Lacking appropriate amino acids) 
1x Nitrogen Base  
Glucose  or Galactose (2% vol/vol)
Yeast Agar Yeast Medium  
agar (2% wt/vol) 
SOC medium Tryptone (2% wt/vol)  
Yeast extract (0.5% wt/vol)  
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2  
20 mM Glucose 
TSB Buffer PEG-3350 (10% wt/vol) 
DMSO (5% vol/vol)  
10 mM MgCl2 
10 mM MgSO4 
Prepared in LB medium 
5x KCM Buffer 100 mM KCl 
30 mM CaCl2 
50 mM MgCl2 
Used at 1x. 
5x Laemmli Buffer 0.25M Tris-HCl (pH 6.8) 
Glycerol (50% vol/vol)  
SDS (8% vol/vol)  
0.5M DTT  
Bromophenol blue (0.1% wt/vol) 
Used at 1x.
10x DNA Loading 
Buffer 
Ficoll 400 (20% wt/vol)  
100 mM EDTA  
SDS (1% vol/vol)  
Bromophenol blue (0.25% wt/vol) 
Xylene Cyanol (0.25% wt/vol)  
Used at 1x.
10x TBE 108 g Tris base 
55 g Boric acid 
40 ml 0.5M EDTA (pH 8.0)  
For 1 liter, diluted to 1x for use. 
10x TBS 121 g Tris base 
88 g NaCl 
For 1 liter, diluted to 1x for use; pH adjusted to 8.0 with HCl
PBS instamed PBS Dulbecco w/o Mg2+ and Ca2+
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1x TBS-Tween®20 1x TBS 
 Tween®20 (0.01% vol/vol) 
10x SDS-PAGE 
Running Buffer 
30 g Tris base (25 mM) 
144 g Glycine (190 mM)  
10 g SDS (10% wt/vol)  
For 1 liter, diluted to 1x for use. 
10x Western Blot 
Transfer Buffer 
30 g Tris base (25 mM)  
144g Glycine (190 mM) 
Ethanol (20% vol/vol)  
For 1 liter, diluted to 1x for use.
Ponceau-S Statin Ponceau-S (0.1% wt/vol)  
Acetic Acid (5% vol/vol) 
2x Stop Buffer Formamide (95% vol/vol)  
20 mM EDTA  
Bromophenol blue (0.1% wt/vol)  
Used at 1x.
2x Helicase Stop 
Buffer 
Ficoll 400 (7% wt/vol) 
20 mM Tris-HCl (pH 7.5)  
20 mM EDTA  
SDS (0.2% vol/vol)  
Used at 1x.
2% Replication Assay 
Stop Solution 
150 mM EDTA 
SDS (2% vol/vol) 
Glycerol (30% vol/vol)  
Bromophenol blue (0.1% wt/vol)
10x DNA Annealing 
Buffer 
100 mM Tris-HCl (pH 8.0) 
500 mM NaCl 
100 mM MgCl2 
Used at 1x. 
2x HBS 280 mM NaCl 
50 mM HEPES 
1.5 mM Na2HPO4
Lysis Buffer 50 mM Na-Phosphate pH 7.0 
150 mM NaCl  
Glycerol (10% vol/vol) 
NP-40  (0.1% vol/vol) 
1 mM TCEP 
0.5 mM EDTA 
EB Buffer (Qiagen) 10 mM Tris-Cl, pH 8.5
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2.2 Molecular Biology Methods  
2.2.1 DNA Cloning  
  The Gateway® cloning technology (Invitrogen) permits the easy transfer of  
insert sequences into a wide number of  expression vectors using two site specific 
recombination reactions. Initially, the insert sequence is cloned into a donor plasmid 
(pDONOR221) that is flanked by recombination sites. Likewise, acceptor plasmids encode 
for different recombination sites, which permits the specific transfer of  the insert from 
donor to acceptor plasmid.  
  To begin, the gene of  interest was flanked by attB sites, introduced by PCR. In 
the first recombination reaction (“BP reaction”), the attB flanked gene of  interest is 
inserted into the pDONOR221 plasmid, mediated by BP Clonase® II. The resulting 
plasmid serves as the DNA bank to be subsequently transferred into the different 
destination vectors. Thereafter, all pDONOR221 plasmids were verified via Sanger 
sequencing. The subcloning into the destination vectors is mediated by the LR Clonase® II 
(“LR reaction”). The resulting plasmids were verified via restriction digest. In general, both 
BP and LR reactions are assembled in a 5 µl reaction (Table 2.1), incubated for 3 hours at 25 
˚C, followed by the addition of  1 µl Proteinase K (20 mg/ml) and 10 minute incubation at 
37˚C. The complete reaction is then used for plasmid propagation via bacterial 
transformation (See 2.2.4).  
2.2.2 Polymerase Chain Reaction (PCR) 
  DNA was amplified using the high fidelity Phusion® Hot Start II  polymerase 
enzyme (New England BioLabs) in a 50 µl reaction volume and assembled as outlined in 
Table 2.2. All analytical and preparative PCRs used 25-35 cycles, while Site-directed 
mutagenesis PCRs used 12-18 cycles, depending on the gene of  interest or flanking DNA 
sequence. All oligonucleotides used in this study were synthesized by Microsynth and are 
listed in Table 2.3. All PCRs were separated on 0.8% TBE agarose gels (100V; 1 hour). 
Table 2.1: BP and LR Reaction Composition
BP Reaction Amount LR Reaction Amount
PCR product (100 ng/µl) 1 µl pDEST_ “Tag” (100 ng/ µl) 1 µl
pDONOR 221 (100 ng/µl) 1 µl pDONOR221_ “gene” (100 ng/µl) 1 µl 
BP Clonase® II 1 µl LR Clonase® II 1 µl 
EB Buffer 2 µl EB Buffer 2 µl 
5 µl  
TOTAL
5 µl 
TOTAL
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Furthermore, PCR products from attB-flanking PCRs were purified using the QIAquick 
Gel Extraction Kit (Qiagen).   
Table 2.2: PCR Reaction Composition                            PCR Protocol
Component 50 µl Reaction Final Concentration Step Temperature Duration 
Template DNA Variable < 250 ng 1. Initial Denaturation 98 ˚C 5 min 
5X Phusion HF Buffer 10 µl 1X 2. Denaturation 98 ˚C 45 sec
10 mM dNTPs 1 µl 200 µM 3. Annealing Variable 45 sec
10 µM Forward Primer 2.5 µl 0.5 µM 4. Extension 72 ˚C Variable
10 µM Reverse Primer 2.5 µl 0.5 µM 5. Final Extension 72 ˚C 10 min
DMSO 1.5 µl 3% 6. Pause 4 ˚C ∞
Phusion Polymerase* 0.5 µl 1.0 units/50 µl PCR Step 2-4 Cycles: Analytical and preparative 25-35X /
SDM: 12-18 X
Nuclease-free H2O up to 50 µl
* Phusion Polymerase Extension Time: 15-30s per kb 
Table 2.3: DNA Oligonucleotides used in PCR
Name Sequence (5’ - 3’) 
oRL 1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGGAGGTGGAGGCCGTC
oRL 2 GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAACTGGCCACCGGGGC
oRL 3 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGAGCCTCTGGGTGGAC
oRL 4 GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAGAACATCATGCCTTCCAATC
oRL 5 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGCAAGCATTTCTTAAAGGTAC
oRL 6 GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAACAATTCTGAGATAACTGCTGC
oRL 7 ATGGAGACCTCAGCACTCAAGC
oRL 8 CACCGCATGTTAGAAGACTTCCTCTGCCCTCACCGCTGCCGGCCTCTGCAACAATCAGCTC
oRL 9 GGAAGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCCGGCCCTATGGAGGTGGAGGCCGTC
oRL 10 CTAACTGGCCACCGGGGC
oRL 11 TCTACATCTCCACAAGTAAGTAGGCTGCCCCTACCTTCACCGCTGCCACTGGCCACCGGGGCCATTG
oRL 12 TACTTACTTGTGGAGATGTAGAAGAAAACCCTGGTCCCATGCAAGCATTTCTTAAAGGTAC
oRL 13 TTAACAATTCTGAGATAACTGCTGC
oRL 60 GACTTGCAAGTACAGTTCACAAATCGG
oRL 61 CCGATTTGTGAACTGTACTTGCAAGTC
oRL 63 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCTCACGATCCGCGGGCACCCGCTTAGC
oRL 66 GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAGACCGTTGCAATACACTGATTTATTATCTG
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2.2.3 Site-directed Mutagenesis (SDM)  
  Site-directed mutagenesis was performed based on the QuikChange® Site-
Directed Mutagenesis kit from Stratagene. Using a plasmid with gene of  interest as the 
DNA template, long PCR primers containing the desired point mutation in the center are 
used in a PCR reaction (See 2.2.2) with the high fidelity Phusion® Hot Start II  polymerase, 
to avoid extra mutations. Following the PCR, the amplified DNA fragments are digested 
with 10U of  DpnI (1-2 hours at 37˚C) (New England BioLabs) to degrade parental DNA. 
The last step is propagation by bacterial transformation (See 2.2.4). The isolated plasmid 
was then checked to verify the desired point mutation and any  accumulation of  extra 
mutations by Sanger sequencing at Microsynth.  
2.2.4 Bacterial Cell Preparation and Transformation   
  Chemically competent Escherichia coli DH10B or DH10bac cells were prepared by 
growing a suspension culture in LB medium to an OD600 = ~ 0.5-0.6, pelleted cells were 
gently resuspended in ice-cold TSB buffer, aliquoted and stored at -80˚C until use. 
Transformations were performed in a 100 µl reaction volume by mixing 1-100 ng DNA in 
5X KCM buffer and 50 µl competent bacteria. Transformation reactions were incubated 
for 10 minutes on ice and subsequently incubated for an additional 15 minutes at RT˚C. 
Next, the reactions were supplemented with 400 µl of  SOC medium and incubated at 37˚C 
with shaking for 1 hour (DH10B) or 4 hours (DH10bac), plated on LB-agar plates 
supplemented with appropriate selection antibiotics and incubated overnight at 37˚C.  
2.2.5 Isolation of  Plasmid DNA  
  After the successful bacterial transformation, 6 ml (mini-prep) or 80 ml (midi-
prep) of  LB medium supplemented with appropriate selection antibiotics were inoculated 
with a single colony and grown overnight at 37˚C on a shaker. The following day the cells 
were centrifuged at 4000 RPM for 10 minutes. Plasmid DNA was isolated using the Qiagen 
Plasmid Mini or Plasmid Midi Kit, which is based on a modified alkaline lysis procedure, 
followed by the adsorption of  DNA onto a silica-based membrane in the presence of  high 
salt. Finally, the bound DNA was washed two times with an ethanol based solution and 
eluted from the membrane with 50 µl (mini-prep) or 200 µl (midi-prep) low salt elution 
buffer according to the manufacturer’s instructions. DNA concentrations were determined 
using the NanoDrop Spectrophotometer (ThermoFisher Scientific).  
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2.2.6 Yeast Transformation  
  To begin, a 50 ml culture of  the yeast strain to be transformed was grown 
overnight at 30˚C in a standard synthetic medium lacking the appropriate amino acids and 
supplemented with 2% glucose (vol/vol). The following morning, the culture was diluted 
to OD600= 0.2 and grown to its exponential phase around OD600= 0.6-0.8. Next, the culture 
was spun down and washed with 25 ml of  sterile water to remove the residual growth 
medium. The culture was then spun down again and resuspended in 1 ml of  sterile water, 
100 µl of  which was used for each transformation. Next, each transformation was spun 
down and the supernatant was removed and assembled as outlined in Table 2.4. Once 
assembled, each transformation was incubated at RT˚C for 1 hour, followed by heat shock 
at 42˚C for 15 minutes. Then, 1 ml of  appropriate synthetic yeast medium was added to the 
transformation and incubated at 30˚C for 2-4 hours. Following the incubation, each 
transformation was spun down and resuspended in 100 µl of  sterile water, plated on 
appropriate selection plates and grown at 30˚C for 2-3 days.  
2.2.7 Reverse Transcription- PCR (RT-PCR) 
  To begin, total RNA was isolated from two 25 ml suspension cultures of  Sf9 
insect cells, one infected with a shRNA Sf9 MIP18 baculovirus and one infected with a 
control baculovirus and grown for 48 hours. After 48 hours, the cells were counted and 
~5.0 x106 cells were taken for RNA isolation using the RNeasy Mini kit (Qiagen) according 
to the manufacturer’s instructions. RNA concentration was determined using the 
NanoDrop Spectrophotometer. cDNA synthesis was prepared using 1 µg total RNA with 
the High Capacity RNA-to-cDNA kit (Applied Biosystems) according to manufacturer’s 
instructions. To determine the relative levels of  Sf9 MIP18 mRNA in insect cells following 
treatment with an shRNA Sf9 MIP18 baculovirus, a RT-PCR was performed. The PCR 
was prepared using 2 µl of  cDNA as template DNA with Sf9 MIP18 specific primers oRL 
63 & 66 as described in Table 2.2.  
Table 2.4: Yeast Transformation Assembly
Component Amount 
DNA: Plasmid: 500 ng 
           PCR: 3-5 µg
Variable
PEG 3550 50% 240 µl
LiAC 1M 36 µl
ssDNA Carrier Salmon 
Sperm (10mg/ml) 
10 µl
d.d. H2O up to 360 µl
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2.3 General Cell Culture Methods  
2.3.1 Cell Culture 
  Human embryonic kidney-293T (HEK-293T) and HeLa cells were grown in 
DMEM (Dulbecco’s Modified Eagle Medium; Gibco) supplemented with 10% fetal calf  
serum (FCS; Gibco) at 37 ˚C and 5% CO2.  Cells were split biweekly in fresh medium upon 
reaching sub-confluency. Sf9 insect cells were grown in a suspension culture with shaking 
in HyClone™ SFX-Insect™ cell media (GE Healthcare) at 25˚C. Insect cells were split 
triweekly by diluting culture to 0.5 x106 cells/ml.  
2.3.2 Plasmid Transfection  
  HEK 293T cells were transfected using calcium phosphate, a widely used 
chemical transfection of  human cells. The basic protocol entails mixing DNA in a buffered 
phosphate solution with calcium chloride, which generates DNA-calcium phosphate co-
precipitates that then enter the cell via endocytosis. In brief, plasmid DNA (5 µg of  each 
plasmid) was mixed with CaCl2 (final 250 mM) in sterile water up to 250 µl. Next, 250 µl of  
2x HBS buffer was added dropwise with low speed vortexing and incubated for 30 minutes 
at RT˚. During the incubation the cell medium was changed to DMEM without FCS. 
Following the incubation, the transfection mixture was added to the cells dropwise, and 
allowed to further incubate for 4-6 hours. The medium was then removed from the cells, 
the cells were washed with PBS and resuspended in DMEM with 10% FCS. The cells were 
grown for 48 hours and harvested. Transfection of  bacmids into Sf9 cells was done using 
TransIT®-LT1 transfection reagent (Mirus) according to the manufacturer’s instructions.  
2.3.3 RNA -Interference  
  For the transient knockdown of  selected genes, HeLa cells were transfected with 
short interfering RNA duplexes (siRNA). To begin, HeLa cells were seeded 1:4 into a 6-
well plate and grown overnight. The following morning (day one), the nearly confluent 
plate was transfected with siRNAs (final 25 nM) using DharmaFECT1 Transfection 
Reagent (Dharmacon). The cells were then incubated for 72 hours at 37˚C and 5% CO2. 
On day four, the cells were diluted 1:5 and re-seeded in a new 6-well plate and transfected 
again with siRNAs as described above. The cells were once again incubated for 72 hours. 
On day seven, the cells were harvested and protein depletion was determined by Western 
blotting. All siRNAs were synthesized by Microsynth and are listed in Table 2.5. 
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2.3.4 Baculoviruses  
  All baculoviruses were generated using the Bac to Bac® Baculovirus Expression 
System (Invitrogen). In general, there are three main steps of  baculovirus generation: (i) 
transform the pFastBac™ based construct containing the gene of  interest into DH10bac 
competent cells to generate recombinant bacmid, (ii) transfect the bacmid into Sf9 insects 
cells to produce recombinant baculovirus particles, and (iii) amplify and titer the baculoviral 
stock to use for recombinant protein expression.  
2.3.4.1 Bacmid Generation  
  To produce recombinant bacmids, a pFastBac based Gateway® vector with 
specific tags was subcloned with the gene of  interest by the LR reaction. The bacmid was 
then transformed into DH10bac competent cells as described above (See 2.2.4). The 
transformants were grown for 48 hours under selective antibiotic pressure, including IPTG 
and X-gal for white-blue screening. All white transformants were then analyzed by PCR 
according to the manufacturer’s instructions, using the universal M13 forward and reverse 
primers. The positive clones were grown in 6 ml suspension culture overnight, and the 
bacmids were then isolated using the QIAmp DNA Mini Kit (Qiagen) and stored at -20 ˚C.  
  Alternatively, bacmids were generated via direct ligation of  the pFastBac vector 
with the gene of  interest. In this case, a shRNA specific for Sf9 MIP18, that was 
commercially produced by Vigene Biosciences. The shRNA was flanked by BamHI and 
HindIII restriction sites, which allowed direct ligation into the pFastBac vector. The 
ligation reaction was performed overnight at 16 ˚C with linearized vector (pFastBac) and 
insert (Sf9MIP18 shRNA) at a 1:3 ratio, with T4 Ligase (Promega) and 10x reaction buffer 
in a 20 µl reaction according to the manufacturer’s instructions. Following the ligation, the 
mixture was transformed into DH10B competent bacteria and bacmids were isolated with 
the QIAmp DNA Mini kit as described above. In addition, the human DNA2 WT bacmid 
was kindly provided by Dr. Cosimo Pinto (University of  Zurich). 
Table 2.5: List of  siRNAs Used in this study
siRNA Sequence (5’ - 3’) 
siControl AGGUAGUGUAAUCGCCUUG (dTdT) 
siMMS19 # 2 AGAAGAGACUGGUGCGCAA (dTdT) 
siMMS19 # 6 ACCUGAUACUGUUCUAUGA (dTdT)
siMIP18 # 5 ACAAGCAACUUGCAGAUAA (dTdT)
siMIP18 # 6 UUAUUGGUCUGUCCAUCAA (dTdT)
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2.3.4.2 Baculovirus Generation   
  To produce baculoviruses, the recombinant bacmids were transfected into Sf9 
cells that were first seeded into a 6-well plate at a density of  2.25 x 106 cells/well and 
allowed to adhere to the plate for 30 minutes at RT˚. Next, the transfection mix was 
prepared by combining 2.5 µg bacmid DNA with the transfection reagent at a 1:3 ratio 
(wt /vol) in 260 µl of  SFX medium. The mix was incubated for 30 minutes at RT˚ and was 
then added to the cells dropwise. The transfected Sf9 cells were incubated for 96 hours at 
25˚C. Afterwards, the medium was recovered, clarified by centrifugation and filter sterilized 
with a 0.22 µM filter, resulting in the P1 baculoviral stock. Next, 5 ml of  Sf9 cells were 
seeded in a culture flask at a density of  1.0 x106 cells/ml and allowed to adhere for 30 
minutes at RT˚C. Thereafter, 1.25 ml of  the P1 stock was used to infect the cells, which 
were then incubated for 96 hours at 25˚C. After 96 hours, the medium was recovered and 
filtered as described above, resulting in the P2 baculoviral stock. The titer of  the P2 stock 
was determined by infecting 2.0 x106 adhered Sf9 cells in a 6-well plate with increasing 
amount of  the baculovirus (0, 12.5, 25, 50, 100, 200 µl). The cells were incubated for 48 
hours at 25˚C. Next, the cells were harvested and lysed as described below (See 2.4.1), and 
protein expression was analyzed by Western blotting. To determine the proper baculovirus 
titer, the minimum volume of  the baculovirus that resulted in maximal protein expression 
was considered the volume defining the multiplicity of  infection (MOI) that is equal to 
(1/2 x106 cells). To amplify the baculovirus, Sf9 cells were seeded at 1 x106 cells/ml in a 50 
ml suspension culture and infected with the P2 baculoviral stock at MOI= 0.1, incubated 
for 96 hours, and recovered and filtered as described above. To assure baculovirus stability, 
all baculoviral stocks were supplemented with 2% FCS (Gibco) and stored at 4˚C.   
2.4 Protein Isolation, Purification, and Analysis  
2.4.1 Whole Cell Lysis  
  Whole cell lysates for human and insect cells were prepared by incubating freshly-
harvested or frozen cell pellets with 5 PCV (packed-cell volume) of  lysis buffer 
supplemented with cOmplete protease-inhibitor cocktail (Roche), for 30 minutes on ice 
with periodic vortexing. Next, the lysate was clarified by centrifugation at 17,200 x g for 30 
minutes at 4˚C. Afterwards, the supernatant was collected and used for further analysis or 
purification. When applicable, protein concentrations were estimated using the Bradford 
Assay.  
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2.4.2 Co-Immunoprecipitation: Protein-Protein Interaction analysis.  
  Whole cell lysates were collected from HEK-293T or Sf9/Sf21 insect cells that 
transiently overexpressed the proteins of  interest either by plasmid transfection or 
baculovirus infection. For each IP sample, 15-20 µl M2 anti-flag affinity resin (Sigma) was 
added to 200-250 µl of  the cleared lysate. The lysate-resin mixture was then incubated 
overnight on a rotary shaker at 4˚C. The following morning, the resin was collected and 
washed 3 times with lysis buffer. Lastly, the resin was boiled in 5 volumes of  1x Laemmli 
buffer, and protein interactions were analyzed by Western blotting.  
2.4.3 Recombinant Protein Purification  
  Dna2 wild-type and mutant variants were expressed from a modified 
pGAL:DNA2 vector that contains two amino N-terminal tags (Flag and HA) and a C-
terminal HIS6 tag, in the protease-deficient S. cerevisiae  strain WDH668. This protocol 
describes purification from a 4l (WT) or 8l (mutant variants) culture. Yeast cells were grown 
to OD600 = ~0.6 in a standard synthetic medium lacking uracil and supplemented with 
glycerol (3% vol/vol) and lactic acid (2% vol/vol) as carbon sources. Expression of  Dna2 
was induced by the addition of  galactose (2% wt/vol) and the cells were grown for an 
additional 6 hours. All subsequent steps were performed at 4˚C. Pelleted cells were 
resuspended in 35 ml TBSG-PI buffer [25 mM Tris-HCl (pH 7.5), 300 mM NaCl, glycerol 
(10% vol/vol), 3 mM β-mercaptoethanol, 10 mM imidazole, 1 mM PMSF and cOmplete 
protease-inhibitor cocktail (Roche, 1 tablet/50 ml)] and lysed in a French press. The lysed 
cells were collected by centrifugation at 27,000 RPM for 45 minutes in the A27-8x 50 rotor 
in a Sorvall Lynx 6000 centrifuge (Thermo-Fischer). The cleared lysates were then 
incubated batch-wise with 5 ml packed Ni2+-NTA agarose (Qiagen) for 1 hour. Following 
incubation, the resin was washed extensively with TBSG-PI high salt buffer (TBSG-PI 
buffer supplemented with NaCl for final concentration of  1M) and transferred to a 10 ml 
column. The bound proteins were eluted from the column with 250 mM imidazole in 
TBSG-PI. The fractions containing protein were pooled, diluted 1:8 with degassed dilution 
buffer (25 mM Tris-HCl (pH 7.5), 150 mM NaCl, glycerol (10% vol/vol), 3 mM β-
mercaptoethanol, 1mM PMSF and cOmplete protease-inhibitor cocktail (Roche, 1 tablet/
50 ml)) and incubated batch-wise with 500 µl of  M2 anti-flag affinity resin (Sigma) for 45 
minutes. Afterwards, the resin was washed extensively with degassed wash buffer [25 mM 
Tris-HCl (pH 7.5), 150 mM NaCl, glycerol (10% vol/vol), and 1 mM β-mercaptoethanol)] 
and transferred to a 5 ml column. Dna2 was eluted with wash buffer supplemented with 3x 
Flag peptide (200 µg/ml; Sigma). Fractions containing protein were pooled and small 
aliquots were frozen in liquid nitrogen and stored at -80˚C. The final protein concentration 
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was estimated by densitometry by comparison with a dilution series of  BSA (New England 
BioLabs) on a 12% polyacrylamide gel stained with Coomassie blue. The protein yields 
were ~40-170 µg and concentrations of  ~157-992 nM for Dna2 wild-type and mutant 
variants. (Figure 4.1). All Dna2 yeast strains and recombinant proteins yRPA ,Pol delta, 
yPCNA, yRFC, and Lig1 were kindly provided by Dr. Maryna Levikova (University of  
Zurich). 
2.4.4 Western Blotting 
 For the analysis and detection of  proteins from cell lysates, Western blots were 
performed. Proteins samples were boiled (95˚C for 5 minutes) in 5x Laemmli sample 
buffer and separated on 12% SDS-PAGE gels at 180 V for 45 minutes in 1x SDS running 
buffer. Afterwards, the proteins were transferred onto nitrocellulose membranes (GE 
Healthcare) at 100 V for 1 hour in 1x transfer buffer. Next, the efficient transfer of  the 
proteins onto the membranes was confirmed by Ponceau-S staining. The membranes were 
then blocked in 5% milk-TBS-T solution for 30 minutes and incubated with primary 
antibody solution overnight at 4˚C. The following morning, the membranes were washed 
extensively in 1x TBS-T and incubated in the appropriate HRP-coupled secondary 
antibody for 1 hour at RT˚ (Table 2.6). After the incubation, the membranes were once 
again washed extensively in 1x TBS-T and the protein signals were developed using the 
Fusion Solo Chemiluminescence Imager (Vilber Lourmat) following the incubation with 
ClarityTM Western ECL Blotting Substrate (Bio-Rad) or SuperSignalTM West Femto 
Maximum Sensitivity Substrate (ThermoFisher Scientific) per manufacturer’s instructions.   
Table 2.6: List of  primary and secondary antibodies used in Western blots.
Primary Antibody Raised In Concentration Used Supplier
Flag M2 Mouse 1:1000 F1804; Sigma-Aldrich
MMS19 Rabbit 1:1000 16015-1-AP; Proteintech
MIP18 Rabbit 1:500 20108-1-AP; Proteintech
RFC5 Goat 1:2000 ab3619; Abcam
RFC2 Mouse 1:500 ab88502; Abcam
RFC4 Mouse 1:1000 ab57917; Abcam
Secondary Antibody Raised In Concentration Used Supplier
Mouse Sheep 1:2500 NA931V; GE Healthcare
Rabbit Donkey 1:2500 NA934V; GE Healthcare
Goat Bovine 1:2500 Sc2350; Santa Cruz
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2.5 Biochemical Assays  
2.5.1 DNA Substrates  
  All oligonucleotides used for DNA substrate preparation were synthesized by 
Microsynth and are listed in Tables 2.6 and 2.7. DNA substrates used in biochemical assays 
contained either a FAM or radioactive label as indicated. 
2.5.1.1 FAM Labeled DNA Substrates 
  The oligonucleotides were FAM labeled on the 3’ or 5’-end during oligo synthesis 
as indicated Table 2.6. DNA substrates were annealed in a 50 µl reaction with a 1:1.5 ratio 
of  labeled to unlabeled oligo in 10x DNA annealing buffer. The substrate mixture was then 
heated to 96˚C for 5 minutes and slowly brought down to 50˚C in a thermocycler. The 
substrates were then placed on the bench to slowly cool down to RT˚. The concentration 
of  the DNA substrates was 200 nM and was used at a final concentration of  10 nM in 
biochemical assays.  
2.5.1.2 Radioactively Labeled DNA Substrates 
  The three oligonucleotides used to prepare the flapped substrate are listed in Table 
2.7. Oligonucleotide 292, which was used to generate the 30 nt flap, was 32P-labeled at the 
3’ end with [alpha-32P] cordycepin-5’ triphosphate (PerkinElmer) using terminal transferase 
(TdT) (New England BioLabs) according to manufacturer’s instructions. Unincorporated 
nucleotides were removed using MicroSpin G25 columns (GE Healthcare). The flapped 
substrates were annealed in a 31.25 µl reaction with a 1:2 ratio of  labeled to unlabeled 
oligos in 10x TdT buffer as described above. The final concentration of  the flapped 
substrate was 100 nM and was used at a final concentration of  1 nM in nuclease assays.  
2.5.2 Nuclease Assays  
  Nuclease assays were performed in a 10 µl reaction volume containing, 25 mM 
Tris-Acetate (pH 7.5), 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA, 1 mM PEP, 80U/ml 
pyruvate kinase, 2 mM Magnesium Acetate, recombinant proteins and as indicated either 
10 nM DNA substrate for FAM labeled substrates or 1 nM DNA substrate for 
radioactively labeled substrates. Where indicated, yRPA was present at 30 nM, which is 
sufficient to fully cover the entire ssDNA in the reaction. Reaction samples were incubated 
at 30˚C for 30 minutes, the reaction was halted by the addition of  2x stop buffer. The 
samples were then heated at 95˚C for 5 minutes and separated on 12 or 20% denaturing 
polyacrylamide gels (ratio acrylamide:bisacrylamide 19:1) in TBE as indicated in the results 
section. 
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  Nuclease Assays with radioactively labeled were fixed in a solution containing 
40% methanol, 10% acetic acid, and 5% glycerol for 30 minutes, without drying, the gels 
were exposed to storage phosphor screens (GE Healthcare) overnight. The following day, 
the screens were scanned by Typhoon Phosphor imager (GE Healthcare). In contrast, 
nuclease assays with FAM labeled substrates were scanned immediately after separation on 
a gel with the Typhoon Phosphor imager (FAM setting). The graphs were prepared in the 
GraphPad Prism7, using mean values from three independent experiments. 
Table 2.6: Oligonucleotides for FAM labeled DNA substrates 
Name Length (nt) Sequence (5’-3’) 
XO1/5’ FAM * 61 GACGCTGCCGAATTCTACCAGTGCCTTGCTAGGACATCTTT
GCCCACCTGCAGGTTCACCC
XO4/3’ FAM * 62 ATCGATAGTCGGATCCTCTAGACAGCTCCATGTAGCAAGGC
ACTGGTAGAATTCGGCAGCGT
FP42-5’ FAM 42 GACGCTGCCGAATTCTACCAGTGCCTTG
CTAGGACATCTTTG
FP42 COMP-Y 42 TTTTTTTTTTTTTTTTTTTTTTTTTTAGAATTCGGCAGCGTC
FP COMP-17 17 GACGCTGCCGAATTCTA
* Oligonucleotides both labeled and unlabeled used in DNA substrate preparation 
DNA substrates Oligonucleotides
Y-structure: XO1 5’*FAM XO1 5’ FAM + XO4
Y-structure: XO4 3’*FAM XO4 3’ FAM + XO1
Y-structure (Y42): FP42 5*FAM FP42 5’ FAM + FP42 COMP-Y
Table 2.7: Oligonucleotides for radioactively labeled DNA Substrates.
Name Length (nt) Sequence (5’-3’) 
X12–4NC 50 GCGATAGTCTCTAGACAGCATGTCCTAGCAAGCCAGAATTC
GGCAGGCTA
Flap 19 X12–4C 19 TAGCCTGCCGAATTCTGGC
292 61 GGTACTCAAGTGACGTCATAGACGATTACATT 
GCTAGGACATGCTGTCTAGAGACTATCGC
DNA substrates Oligonucleotides 
30 nt FLAP 292* 3’ + X12-4NC + Flap 19 X12-4C
36
2.5.3 Helicase Assays  
  Helicase assays were performed in 10 µl reaction volume containing, 25 mM Tris-
Acetate (pH 7.5), 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA, 0.5 mM Magnesium Chloride, 
50 nM competitor oligo, recombinant proteins, and 10 nM FAM labeled DNA substrate. 
Reactions were incubated at 30˚C for 30 minutes and the reaction was halted by the 
addition of  2x helicase stop buffer. Reactions were then supplemented with 1 µl of  
Proteinase K (20mg/ml) and incubated for 10 minutes at 37˚C. Next, the control reaction 
was heated to 95˚C for 5 minutes, and all samples were separated on a 10% native 
polyacrylamide gel in TBE  (ratio acrylamide:bisacrylamide 19:1). The gel was then scanned 
by the Typhoon Phosphor imager (FAM setting).The graphs were prepared in the 
GraphPad Prism7, using mean values from three independent experiments. 
2.5.4 Replication Assays  
  Replication assays were performed with a 3.197 kb-long ssDNA plasmid (pRichi) based 
substrate with the pR_T30flap (5’- TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTACCA- 
3’) oligo annealed to generate a 30 nt flap as previously described (Levikova & Cejka, 
2015). In a 15 µl reaction volume, 25 mM Tris-acetate pH 8.5, 10 mM magnesium acetate, 
125 mM NaCl, 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA, 1 mM phosphoenol pyruvate, 80 
U/ml pyruvate kinase, 100 M dNTPs (each) and 6.4 nM (molecules, 100 ng) ssDNA 
substrate were mixed together. Afterwards, PCNA (20 nM), RFC (20 nM) and RPA (1 µM, 
concentration saturating 100% of  DNA) were added to the reaction and pre-incubated for 
1 min at 30˚C. Next, Pol δ (5 nM) Dna2 ( as indicated) and Lig1 (20 nM) were added to the 
reaction and further incubated at 30˚C for 1 hour. The reactions were halted by the 
addition of  5 µl of  2% replication assay stop solution and supplemented with 1 µl of  
Proteinase K and incubated for 10 minutes at 37˚C. The reactions were then separated on a 
1% agarose gel containing GelRed® (1:10,000 vol/vol; Biotium) and analyzed by an Alpha 
Imager gel imaging system. The experiments and pRichi ssDNA plasmid and pR_T30 flap 
oligo were kindly performed and provided by Dr. Maryna Levikova (University of  Zurich). 
The graphs were prepared in the GraphPad Prism7, using mean values from three 
independent experiments. 
37
2.6 Radioactive 55Fe  Incorporation 
2.6.1 Yeast 55Fe Incorporation  
  To obtain clear evidence that RFC5 binds an FeS cluster, an 55Fe-incorporation 
assay was conducted as described previously (Pierik et al., 2009). In brief, human GFP-
tagged RFC5 was constitutively expressed in a yeast strain in which Flag-tagged MMS19 is 
expressed in a galactose-inducible manner (PGAL Flag-MMS19). Following iron starvation, 
the yeast cells were radiolabeled with 55Fe (PerkinElmer). Next, yeast cell extracts were 
prepared and GFP-RFC5 was immunopurified with GFP-Trap® agarose resin 
(Chromotek) for 1 hour on a rotary rotor at 4˚C. Next, the resin was washed extensively 
and then resuspended in 50 µl of  sterile water and transferred to a counting tube and 
mixed with 1 ml of  Ultima Gold™ liquid scintillation cocktail (PerkinElmer). The extent 
of  55Fe incorporation was measured by liquid scintillation counting on the Tri-Carb 2000 
CA (Packard) with settings appropriate for 3H. In addition, to examine the dependency on 
MMS19 for iron incorporation, the assay was performed under normal (galactose-
containing medium) conditions and MMS19-depleted (glucose-containing medium) 
conditions. RFC5 expression levels were evaluated by Western blotting to verify that any 
decrease in 55Fe incorporation was not a result of  RFC5 destabilization.  
2.6.2 Sf9 55Fe Incorporation  
  The radiolabeling of  Sf9 insect cells with 55Fe is an efficient assay for the 
estimation of  the de novo biogenesis of  FeS cluster containing proteins in vivo. The Sf9 Fe 
incorporation assay was developed based on the protocol from Pierik and colleagues, who 
measured Fe incorporation in yeast cells (Pierik et al., 2009). To begin, 20 ml Sf9 
suspension cultures are seeded at a density of  1.5 x106 cells/ml. Next, the cells were 
infected with the  appropriate baculovirus according to its MOI. Next, the cells were 
radiolabeled with the addition of  200 µl of  0.1M Na ascorbate, which prevents the 
formation of  ferric precipitates in the growth media, and 20 µl of  55FeCl3 (PerkinElmer). 
The cells were then incubated for 48 hours at 25˚C. Afterwards, the cells were harvested by 
centrifugation (1500 RPM, 10 mins, 4˚C) and the supernatant discarded. To remove 
residual 55FeCl3, cells were washed with 5 ml of  citrate buffer [50 mM Na Citrate, 1 mM 
EDTA in 1x PBS] and spun down. Again, the supernatant was discarded and the cells were 
washed with 1x PBS to remove residual citrate buffer. Thereafter, the cell pellet was lysed 
as described above (See 2.4.1). The resulting lysate was then immunoprecipitated (IP) on 20 
µl pre-equilibrated M2 Flag beads on a rotor at 4˚C for 1 hour. After the IP, the beads were 
washed 6x 5 minutes in lysis buffer. Meanwhile, the liquid scintillation tubes were prepared, 
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by adding 1 ml of  Ultima Gold™ liquid scintillation cocktail to the counting tubes. After 
washing, the supernatant was removed and the beads were resuspended in 50 µl of  sterile 
water and added to the counting tubes. The tubes were vortexed gently for 1 min/sample, 
then taken for counting on the Tri-Carb 2000 CA.55Fe radioactivity associated with the 
beads was counted with settings appropriate for 3H as described above. The remaining 
beads from the IP were stored in 40 µl of  2x loading dye. To check protein expression/
capture, 10 µl were loaded on a 12% SDS gel, and stained with Coomassie blue. 
2.7 Bioinformatics  
2.7.1 Multiple-Sequence Alignment  
  Primary Sequence alignment was performed by using Clustal Omega algorithms 
with default settings, accessed through Uniprot (www.uniprot.org). Accession Numbers of  
proteins: RFC5: B5DF29 (R. norvegicus), P40937 (H. sapiens), Q8CFZ9 (M. musculus), 
Q6DRK4 (D. rerio), and P38629 (S. cerevisiae). RFC2: P35250 (H. sapiens); RFC3: P40938 
(H. sapiens); RFC4: P35249 (H. sapiens).  
2.7.2 Protein Structure Analysis  
  Analysis of  mouse DNA2 structure was performed using UCSF Chimera. 
Structure from (Zhou et al., 2015), PDB Code: 5EAX 
2.7.3 Quantification of  Biochemical Assays and Protein Purification  
  Nuclease and helicase activities were quantified using ImageJ software (NIH); 
product formation was calculated by measuring the remaining substrate compared to 
control samples; the integrated density parameter of  each band was measured and adjusted 
by eliminating the integrated density value of  the background. Purified proteins were also 
quantified with ImageJ by comparing the purified proteins with a dilution series of  BSA.  
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3. Results 
Aim 1: Identifying Potential Novel Nuclear FeS Cluster Proteins: RFC5 
  A common characteristic of  all currently known nuclear FeS cluster proteins is 
their interaction with the MMS19-MIP18 complex, core components of  the CIA 
machinery. RFC5 was identified as a potential interaction partner of  MMS19 via mass 
spectrometry (Stehling et al., 2012). In addition Rfc3, the yeast counterpart to RFC5 was 
shown to be synthetic lethal with mms19∆ (Collins et al., 2007). Furthermore, in silico 
multiple sequence alignment revealed five conserved cysteine residues that could potentially 
function in coordinating an FeS cluster (Figure 3.1). Therefore, we hypothesized that RFC5 
could potentially bind an FeS cluster as a cofactor.  
3.1 RFC5 Interaction Study with CIA Machinery Components MMS19 & MIP18  
  To confirm the interaction between RFC5 and the CIA machinery, extracts from 
Sf9 or Sf21 insect cells transiently co-expressing RFC5 along with MMS19 or MIP18 were 
used for co-IP experiments. The constituents of  the isolated complexes were then 
identified by Western blotting. Here we show that RFC5 physically interacts with both 
MMS19 and MIP18 independently and bidirectionally in vitro (Figure 3.2). In addition to co-
IP experiments in insect cells, the physical interaction of  RFC5 with MMS19 and MIP18 in 
HEK-293T cells was also tested. Cells were transfected using Calcium Phosphate. As 
before in insect cells, RFC5 was co-expressed with MMS19 and the putative complexes 
were isolated and analyzed by Western blotting. In initial experiments, we observed that the 
expression levels of  RFC5 were very low (see also Figure 3.3: WCE lanes 1,3,6). Since it has 
been shown that RFC5 and RFC2 have a pairwise subunit interaction (Majka & Burgers, 
2004), we additionally co-expressed the RFC2 subunit to test if  RFC5 expression was 
stabilized, which indeed was the case (Figure 3.3: WCE lanes 2,5,7). When expressed in the 
presence of  RFC2, RFC5 was pulled down by Flag-tagged MMS19 but not by Flag-tagged 
ALC1, which was used as a control in the co-IP experiments. Interestingly, RFC5 
interaction with RFC2 does not interfere with its interaction with MMS19, indicating that 
the interaction between MMS19 and RFC5 is specific (Figure 3.3). A similar result was 
obtained when we tested the interaction of  RFC5 with MMS19 and MIP18 simultaneously, 
utilizing a plasmid encoding Flag-tagged MMS19 and untagged MIP18 separated by the 
self-cleaving peptide T2A, allowing us to obtain approximately the same expression of  
MMS19 and MIP18 (Szymczak et al., 2004). These data show that RFC5 interacts with 
MMS19 and MIP18 suggesting that it may incorporate an FeS cluster as a cofactor.  
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TR|B5DF29|B5DF29_RAT   --MAAAPSQQQPRAARARNLPWVEKYRPQTLADLISHQDILSTIQKFISEDRLPHLLLYG 58
SP|P40937|RFC5_HUMAN   METSALKQQEQPAATKIRNLPWVEKYRPQTLNDLISHQDILSTIQKFINEDRLPHLLLYG 60
TR|Q8CFZ9|Q8CFZ9_MOUSE -------HASAHASAHASAHASAHASGPQTLADLISHQDILSTIQKFISEDRLPHLLLYG 53
TR|Q6DRK4|Q6DRK4_DANRE ------MASTSKTQPQARNLPWVEKYRPQTLDDLISHQDILSTIQKFISEDRLPHLLFYG 54
SP|P38629|RFC3_YEAST   -------MSTSTEKRSKENLPWVEKYRPETLDEVYGQNEVITTVRKFVDEGKLPHLLFYG 53
TR|B5DF29|B5DF29_RAT   PPGTGKTSTILACAKQLYKDKEFGSMVLELNASDDRGIDIVRGPILSFASTRTIFKRGFK 118
SP|P40937|RFC5_HUMAN   PPGTGKTSTILACAKQLYKDKEFGSMVLELNASDDRGIDIIRGPILSFASTRTIFKKGFK 120
TR|Q8CFZ9|Q8CFZ9_MOUSE PPGTGKTSTILACAKQLYKDKEFGSMVLELNASDDRGIDIVRGPILSFASTRTIFKKGFK 113
TR|Q6DRK4|Q6DRK4_DANRE PPGTGKTSTILACARQLYKDKEFNSMVLELNASDDRGIDVVRGPILSFASTRTIFKKGFK 114
SP|P38629|RFC3_YEAST   PPGTGKTSTIVALAREIYG-KNYSNMVLELNASDDRGIDVVRNQIKDFASTRQIFSKGFK 112
TR|B5DF29|B5DF29_RAT   LVILDEADAMTQDAQNALRRVIEKFTENTRFCLICNYLSKIIPALQSRCTRFRFGPLTPE 178
SP|P40937|RFC5_HUMAN   LVILDEADAMTQDAQNALRRVIEKFTENTRFCLICNYLSKIIPALQSRCTRFRFGPLTPE 18
TR|Q8CFZ9|Q8CFZ9_MOUSE LVILDEADAMTQDAQNALRRVIEKFTENTRFCLICNYLSKIIPALQSRCTRFRFGPLTPE 173
TR|Q6DRK4|Q6DRK4_DANRE LVILDEADAMTQDAQNALRRVIEKFTENTRFCLICNYLSKIIPALQSRCTRFRFGPLSQN 174
SP|P38629|RFC3_YEAST   LIILDEADAMTNAAQNALRRVIERYTKNTRFCVLANYAHKLTPALLSRCTRFRFQPLPQE 172
TR|B5DF29|B5DF29_RAT   LMVPRLEHVVQEENVDISEDGMKALVTLSSGDMRRALNILQSTNMAFG-----KVTEETV 233
SP|P40937|RFC5_HUMAN   LMVPRLEHVVEEEKVDISEDGMKALVTLSSGDMRRALNILQSTNMAFG-----KVTEETV 235
TR|Q8CFZ9|Q8CFZ9_MOUSE LMVPRLEHVVQEENVDISEDGMKALVTLSSGDMRRALNILQSTNMAFG-----KVTEETV 228
TR|Q6DRK4|Q6DRK4_DANRE QMIPRLEHVIQQESIDITPDGMKAIVTLSTGDMRRSLNILQSTHMAYG-----KVTEETV 229
SP|P38629|RFC3_YEAST   AIERRIANVLVHEKLKLSPNAEKALIELSNGDMRRVLNVLQSCKATLDNPDEDEISDDVI 232
                        
TR|B5DF29|B5DF29_RAT   YTCTGHPLKTDIANILDWMLNQDFTTAYKNIMELKTLKGLALHDILTEVHLFVHRVDF-P 292
SP|P40937|RFC5_HUMAN   YTCTGHPLKSDIANILDWMLNQDFTTAYRNITELKTLKGLALHDILTEIHLFVHRVDF-P 294
TR|Q8CFZ9|Q8CFZ9_MOUSE YTCTGHPLKTDIANILDWMLNQDFTTAYKNIMELKTLKGLALHDILTEVHLFVHRVDF-P 287
TR|Q6DRK4|Q6DRK4_DANRE YTCTGHPLRSDIANILDWALNKDFTTAYNQILELKTLKGLALHDILTEVHLLIHRVDF-P 288
SP|P38629|RFC3_YEAST   YECCGAPRPSDLKAVLKSILEDDWGTAHYTLNKVRSAKGLALIDLIEGIVKILEDYELQN 292
                     
TR|B5DF29|B5DF29_RAT   SSVRMHLLTKMADIEYRLSVGTSEKIQLSSLIAAFQVTRDLIVAEA-- 338
SP|P40937|RFC5_HUMAN   SSVRIHLLTKMADIEYRLSVGTNEKIQLSSLIAAFQVTRDLIVAEA-- 340
TR|Q8CFZ9|Q8CFZ9_MOUSE SSVRIHLLTKMADIEYRLSVGTSEKIQLSSLIAAFQVTRDLIVAEA-- 333
TR|Q6DRK4|Q6DRK4_DANRE PSIRMGLLIKLADIEYRLASGTSEKIQLSSMVAAFQAVRDIVVSDG-- 334
SP|P38629|RFC3_YEAST   EETRVHLLTKLADIEYSISKGGNDQIQGSAVIGAIKASFENETVKANV 340
                        
Figure 3.1 Multiple Sequence Alignment of  RFC5. Multiple sequence alignment of  RFC5 reveals 
five conserved cysteines that may potentially function in FeS cluster coordination. Sequences aligned 
from rat, human, mouse, zebrafish, and yeast. 
WCE
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Ab: RFC5
Ab: MMS19
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A. 
B.
Figure 3.2 RFC5 Interacts with CIA Machinery Components MMS19/MIP18. (A.) Co-IP of  
RFC5 co-expressed with MMS19 in Sf21 insect cells. (B.) Co-IP of  RFC5 co-expressed with MIP18 in 
Sf9 insect cells. 
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3.2 Yeast 55Fe Incorporation Assay with RFC5  
  To obtain clear evidence that RFC5 coordinates an FeS cluster, we performed an 
55Fe incorporation assay in yeast as described in (Sec. 2.6). Human GFP-tagged RFC5 was 
overexpressed in a yeast strain in which Flag-tagged MMS19 is expressed in a galactose-
inducible manner (PGAL Flag-MMS19). The extent of  55Fe incorporation was measured by 
liquid scintillation counting. In initial experiments GFP-RFC5 expression was unstable, 
which resulted in unreliable measurements (data not shown). Therefore, to enable stable 
expression of  RFC5, we generated a GFP tagged RFC5 yeast strain coupled with RFC2 
using the T2A peptide as described above. Using the newly-generated yeast strain, we re-
performed the 55Fe incorporation assays. Across four biological replicates we were able to 
detect the presence of  iron in RFC5, albeit at low levels. In addition to low detection levels, 
the counts were highly variable across all experiments (Figure 3.4A). However, after data 
normalization, we were able to demonstrate a significant difference in iron incorporation 
              293T 
Flag-ALC1 + + - - - - -
Flag-MMS19 - - + + + - -
Flag-MMS19-T2A-
MIP18 - - - - - + +
RFC5 + + + - + + +
myc-RFC2 - + - + + - +
1 2 3 4 5 6 7
WCE
IP
Ab: Flag
Ab: Flag
Ab:MIP18
Ab: RFC5
Ab: Myc
Ab: Myc
Ab: RFC5
Ab:MIP18
Figure 3.3 RFC5 Interacts with CIA Machinery Components MMS19/MIP18 in HEK 293T. 
Like in insect cells, RFC5 interacts with both MMS19 and MIP18. Co-expression of  RFC2 stabilizes 
RFC5 expression but RFC2 does not interact with the CIA machinery. 
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between the MMS19 expressing (galactose-containing medium) and non-MMS19 
expressing (glucose-containing medium) conditions (Figure 3.4B). In addition, after Western 
blot analysis of  the isolated complexes, we discovered that RFC5 expression was greatly 
stabilized in the presence of  RFC2 (Figure 3.4C). Although we were able to detect the 
presence of  iron in RFC5, the low counts and high variability between experiments led us 
to seek another method to detect the presence of  iron in RFC5 more reliably.  
3.3 55Fe Incorporation in Sf9 Insect Cells  
  Due to the challenges of  expressing RFC5 in yeast for iron incorporation analysis, 
a new method to detect the presence of  iron in candidate proteins was required. Therefore, 
we developed a new method using a cellular system closer related to humans. We made use 
of  Spodoptera frugiperda Sf9 insect cells, which are widely used for protein expression and 
recombinant protein purification. To validate the assay, we analyzed the iron incorporation 
in a known FeS cluster protein, ChlR1. As a control we used ChlR1’s FeS binding mutant 
C267S as described in (Sec. 2.7). Our results demonstrated a nearly a 10-fold decrease in 
55Fe incorporation in the C267S mutant compared to ChlR1 WT. In addition, 55Fe 
incorporation counts were higher than in yeast, which allowed us to see a clear difference 
between the WT and FeS binding mutant, proving to be a robust method for the detection 
of  the de novo biogenesis of  FeS cluster proteins in vivo (Figure 3.5).  
Figure 3.4 Yeast iron incorporation assay . 
(A.) Liquid scintillation counting measurements 
for RFC5 iron incorporation (Counts/min). 
(B.)Relative levels of  55Fe incorporation in the 
presence (GAL) or absence (GLU) of  MMS19 
after data normalization. n=4; p: <0.001 (C.) 
Representative Western blot of  the isolated RFC5 
complexes. RFC5 expression levels are stabilized 
in the presence of  RFC2. 
GAL GAL GLU GLU 
WCE IP
Ab: GFP
Ab: FLAG
Ab: RFC2
A. 
C. 
Experiment # Galactose (+ MMS19) Glucose (-MMS19)
1 144 50
2 281 89
3 144 52
4 203 66
B. 
Galactose Glucose
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Re
la
tiv
e 
55
Fe
 In
co
rp
or
at
io
n
GFP-RFC5-T2A-RFC2
***
44
  To enable the stable expression of  RFC5 in insect cells, we generated a Flag-
tagged baculovirus coupled with RFC2, using the T2A peptide as described above. To 
ensure our construct resulted in stable RFC5 expression, we performed a series of  
interaction studies in HEK-293T cells. Plasmids encoding Flag-tagged RFC5, Myc-tagged 
RFC2 and Flag-tagged RFC5-T2A-RFC2 were transiently over expressed with MMS19, and 
the isolated complexes analyzed by Western blotting. As suspected, the expression of  
RFC5 was greatly stabilized in the presence of  RFC2. Surprisingly, we found that  the T2A 
peptide in the RFC5-T2A-RFC2 construct eliminated RFC5s interaction with MMS19 
(Figure 3.6). Therefore, we tested the iron incorporation in RFC5 alone and with the co-
expression with RFC2, using ChlR1 WT as a positive control. Across three biological 
replicates, we were only able to detect background levels of  iron in RFC5 when compared 
with the known FeS protein ChlR1 (Figure 3.7). These data suggest that RFC5 is unlikely to 
coordinate an FeS cluster as a cofactor.  
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Figure 3.6 RFC5 T2A RFC2 Construct 
Eliminates MMS19 Interaction. 
RFC5 stability is increased in the presence 
of  RFC2. However, T2A peptide eliminates 
RFC5’s interaction with MMS19.  
Figure 3.5 Sf9 55Fe Incorporation Assay 
Validation.  
Counts per min in ChlR1 WT and FeS binding 
mutant C267S. The C267S mutant exhibits ~10 
fold less incorporation compared to the WT. 
Inset: Protein Capture, 12% SDS; Coomassie 
blue staining. n= 3; p: 0.0062 
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3.4 Knock-down of  CIA Machinery Components MMS19/MIP18 Does Not Affect RFC5 
Expression  
  Since it was previously shown that the loss of  MMS19 resulted in lower 
expression levels for multiple FeS proteins, we reasoned that the transient knockdown of  
CIA machinery components MMS19 and/or MIP18 via siRNA treatment would destabilize 
RFC5, resulting in lower expression levels (Gari et al., 2012). Both MMS19 and MIP18 
were knocked down using two siRNAs each as described in (sec. 2.3.3). Expression levels 
were analyzed by Western blotting. The siRNAs targeting MMS19 both effectively reduced 
expression levels in HeLa cells (Figure 3.8). The MIP18 knockdown was less efficient, but 
was significantly reduced in comparison to the control siRNA. Interestingly, MIP18 
expression in MMS19 knockdown cells was also reduced, which is in line with a recent 
study that demonstrated MMS19 expression is required for stable MIP18 expression 
(Odermatt & Gari, 2017). Ultimately, the levels of  RFC5 were unaffected by the 
knockdown of  the CIA machinery components (Figure 3.8). Taken together with the Sf9 
55Fe incorporation data, these results suggest that RFC5 is unlikely to coordinate an FeS 
cluster as a cofactor. Further studies will be required to identify the functional relevance of  
RFC5’s interaction with the CIA machinery.     
Figure 3.7 Sf9 55Fe Incorporation Assay: 
RFC5 
Mean 55Fe incorporation levels (Counts/min) in 
ChlR1 WT, RFC5 alone, and RFC5/RFC2. 
RFC5 55Fe incorporation only detects 
background levels; RFC5 likely does not 
coordinate FeS cluster  Inset: Protein Capture, 
12% SDS; Coomassie blue staining. n= 3 
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Figure 3.8 RFC5 expression levels following knockdown of  CIA machinery components. 
The transient knockdown of  CIA machinery components MMS19 and MIP18 does not affect the 
expression of  endogenous RFC5.  
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4. Results 
Aim 2: Elucidating the Role of  the Iron-Sulfur Cluster in the Nuclease/Helicase 
Dna2 
   
4.1 Purification of  Dna2  
In 2012, Pokharel and Campbell confirmed Dna2 as a bona fide FeS cluster protein 
(Pokharel & Campbell, 2012). In this study, they showed that loss of  the FeS cluster was 
detrimental to Dna2’s nuclease and ATPase activities in vitro. However, considering the 
fragile nature of  FeS clusters and their sensitivity to oxidation and long dialysis procedures, 
we asked whether the integrity of  the FeS cluster was maintained in this earlier study. 
Therefore, wild-type, nuclease-dead (E675A), helicase-dead (K1080E), FeS binding mutant 
(C771A), double-mutants (C771A/E675A) and (C771A/K1080E) Dna2, were purified 
using an optimized protocol as described previously (Levikova et al., 2013)(Figure 4.1) (See 
2.4.2).
Cell disruption
Ni-NTA agarose              
anti-FLAG affinity resin            
Reducing condtions 
6 hours
A. 
B. 
C771A K1080EE675A
E675A = Nuclease-dead 
C771A = FeS binding mut. 
K1080E = Helicase-dead
FLAG HIS
C. 
Figure 4.1 Dna2 Purification  
(A.) Dna2 constructs with indicated point-mutations. (B.) Purification Schematic (C.) Wild-type and 
mutant proteins of  Dna2 
47
4.2 Biochemical Analysis  
4.2.1 Dna2 Nuclease Assays  
  As noted above, previous studies have shown that, in the absence of  the FeS 
cluster, Dna2 nuclease activity is almost completely lost (Pokharel & Campbell, 2012). 
Therefore, we tested our recombinant Dna2 preps and found that for the wild-type, 
maximum cleavage was observed at all protein concentrations, whereas the FeS (C771A) 
and FeS-helicase-dead (C771A/K1080E) double mutant showed impaired but not 
abolished nuclease activity. As expected, the FeS-nuclease-dead (C771A/E675A) double 
mutant showed no nuclease activity (Figure 4.2). Nuclease assays were performed using 3’ 
FAM labeled oligo-based DNA substrates and analyzed on a denaturing gel.
Next, we tested the speed at which the wild-type or FeS binding mutant (C771A) 
degrades its DNA substrate. Therefore, as described in (Sec. 2.5.2) we performed a time-
course nuclease assay using 45nM of  WT or FeS binding mutant Dna2. Wild-type Dna2 
was able to degrade its substrates very rapidly, reaching maximum cleavage by 60 seconds, 
whereas for the FeS binding mutant significant substrate cleavage was only seen after 5 
minutes, increasing steadily with time. (Figure 4.3A). These results indicate that the FeS 
cluster in Dna2 is required for rapid nuclease activity and that loss of  the FeS cluster 
doesn’t completely eliminate nuclease activity in Dna2. 
(nM)
Y-Structure
Nuclease Products
WT C771A C771A/E675A C771A/K1080E
Figure 4.2 Nuclease activity of  wild-type and mutant proteins (4-32nM). 10nM Y-structure 
DNA substrate was used in the nuclease reaction containing: 25mM Tris-Acetate (pH 7.5), 1mM 
dithiothreitol (DTT), 0.1mg/ml BSA, 1mM ATP, 2 mM Mg Acetate, 1mM phosphoenolpyruvic acid 
(PEP), and 80U/ml pyruvate kinase. 12% denaturing gel.
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  Considering that the FeS binding mutant’s (C771A) nuclease activity was 
concentration dependent, we then tested the minimum concentration required of  wild-type 
Dna2 to reduce its nuclease activity to that of  a maximum concentration of  C771A Dna2. 
Therefore, we performed a nuclease assay as described in (Sec. 2.5.2). Wild-type Dna2 was 
titrated between 0.125-32nM and C771A Dna2 4-32nM. These experiments revealed that 
wild-type Dna2’s nuclease activity is comparable to 32nM of  C771A Dna2 at a 
concentration of  0.5nM (Figure 4.3B). Collectively, our results indicate the loss of  the FeS 
cluster in Dna2 significantly reduces its nuclease activity but does not abrogate it 
completely. 
Figure 4.3 Nuclease Activity of  WT and FeS Mutant (A.) Nuclease activity of  45nM wild-type 
(left panel) and FeS binding mutant (right panel), 100µl reaction volume, 10µl samples taken at 
indicated time points. Inset: Quantification: Averages shown n=3, error bars; s.e.m.(B.) Nuclease 
activity of  wild-type, titrated between 0.125-32nM (left panel) and FeS binding mutant (right panel) 
titrated between 4-32nM; 10nM Y-structure DNA substrate was used in the nuclease reactions 
containing: 25mM Tris-Acetate (pH 7.5), 1mM dithiothreitol (DTT), 0.1mg/ml BSA, 1mM ATP, 2 
mM Mg Acetate, 1mM phosphoenolpyruvic acid (PEP), and 80U/ml pyruvate kinase. Inset: 
Quantification:Averages shown n=3, error bars; s.e.m. 12% denaturing gel.
A.
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4.2.2 Dna2 Helicase Assays  
  The nuclease activity of  Dna2 was reported to be required for all of  its in vivo 
functions and considered its main functional role. However, Dna2 contains a Superfamily I 
helicase domain, shown to possess weak unwinding capability. It was later shown that Dna2 
possesses cryptic but potent helicase activity comparable to a number of  other helicases, 
only observable after nuclease inactivation (Levikova et al., 2013). These data suggested 
that the potent Dna2 nuclease activity inhibits substrate unwinding by cleaving 5’ flaps 
required for helicase loading. Considering the reduction in nuclease activity after the loss of  
the FeS cluster, we hypothesized that loss of  the FeS cluster may result in increased helicase 
activity. To test this, we performed helicase assays using recombinant nuclease-dead 
(E675A), FeS binding- (C771A) and double mutant (C771A/E675A) Dna2. In addition, to 
confirm that our reaction products were the result of  ATP-dependent helicase activity, we 
tested helicase activity in the absence of  ATP as described in (Sec. 2.5.3).  
  As expected, the nuclease-dead (E675A) mutant exhibited potent helicase activity 
and reached a minimum of  50% unwinding at all protein concentrations. The FeS-
nuclease-dead double mutant (C771A/E675A) exhibited reduced helicase activity in a 
concentration-dependent manner, which points to a critical role of  the FeS cluster in 
sustaining helicase activity (Figure 4.4A). Helicase reactions without ATP resulted in no 
unwinding, which was expected as Dna2 is an ATP-dependent helicase (Figure 4.4B). 
Interestingly, the FeS binding mutant (C771A) exhibited slight helicase activity that 
decreased in a concentration-dependent manner, which was lost in the absence of  ATP. 
Furthermore, the decrease in helicase activity in the C771A mutant was the result of  
simultaneous nuclease activity (Figure 4.4C). Moreover, we investigated whether or not 
Dna2 WT exhibits helicase activity compared to the FeS binding mutant (C771A). 
Surprisingly, Dna2 WT exhibited helicase activity at low protein concentrations, while, as 
expected, Dna2 C771A exhibited only slight helicase activity (Figure 4.5). Our data suggests 
that the loss of  the FeS cluster in Dna2 does not stimulate Dna2’s helicase activity, but 
rather is critical for both its nuclease and helicase activities.  
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Figure 4.4 Dna2 Helicase Assays (A/B). Helicase activity of  nuclease-dead (E675A) and 
FeS/nuclease-dead (C771A/E675A) with or without ATP. Inset A: Quantification of  the 
E675A and E675A/C771A helicase activity. Averages shown n=3; error bars, s.e.m. (C.) 
Helicase activity of  the FeS binding mutant (C771A) with or without ATP. Protein 
concentrations as indicated; 10nM 5’FAM labelled Y-structure DNA substrate was used in a 
10μl reaction containing: 25mM Tris-Acetate (pH 7.5), 1mM dithiothreitol (DTT), 0.1mg/ml 
BSA, 2mM ATP, 1mM Mg Acetate and, 50nM of  DNA competitor. Reactions incubated at 30 
̊C for 30 minutes. The reaction was stopped by addition of  2X stop solution (7% Ficoll 400, 
20mM Tris- Hcl (pH 7.5), 20mM EDTA, 0.2% SDS, bromophenol blue, and 10mg/ml 
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4.2.3 Okazaki Fragment Maturation  
  During DNA replication, lagging strand synthesis occurs in short stretches 
termed Okazaki fragments. Prior to the adjacent fragments ligation, any flaps resulting 
from the displacement of  the 5’ end of  the Okazaki fragment must be resected. It has been 
shown that Dna2 functions upstream of  Fen1 in processing flaps coated by RPA, resulting 
in a shorter flap that is then processed by Fen1. However, it was later shown that Dna2 can 
cleave at or near the base of  the flap without the further requirement for Fen1 processing 
(Levikova & Cejka, 2015). Since the latter study had significantly more active Dna2 rapidly 
purified under reducing conditions, we hypothesized that the integrity of  the FeS cluster in 
Dna2 may be required for cleavage at or near the base, and that the FeS cluster may 
regulate the cleavage site of  Dna2 in Okazaki fragment processing. To test this, we used 
recombinant wild-type and 10 times the concentration of  the FeS binding mutant (C771A) 
Dna2 in a nuclease assay that utilizes a substrate mimicking a structure that arises upon 
displacement synthesis during Okazaki fragment processing (Figure 4.6A) (Levikova & 
Cejka, 2015). To assess Dna2 WT and Dna2 C771A’s ability to cleave at the base of  an 
Okazaki-like fragment, we performed nuclease assays as described in (Sec. 2.5.2), using 1nM 
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Figure 4.5 Dna2 Helicase Assays WT and FeS Mutant (A/B). Helicase activity of  Dna2 WT. 
(B.) Helicase activity of  the FeS binding mutant (C771A). Protein concentrations as indicated; 
10nM 5’FAM labelled Y-structure DNA substrate as described in Figure 4.4. 
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flapped substrate in the presence of  RPA and analyzed them on a denaturing gel. As 
expected, the majority of  Dna2 WT’s cleavage products are 33 nucleotides long, indicating 
cleavage at or near the base. In contrast, Dna2 C771A is unable to efficiently cleave at the 
base, where the majority of  cleavage products are larger than 35 nucleotides, despite a 
similar rate of  nuclease activity (Figure 4.6B). 
Figure 4.6 Okazaki Fragment Maturation Nuclease Assay (A). 30 nucleotide flap substrate that 
mimics a structure that arises upon displacement synthesis during Okazaki Fragment processing. (B.) 
Wild-type (0.3125-5nM) Dna2 and FeS binding mutant (3.125-50 nM), exhibit different cleavage 
patterns. Inset: Quantification of  nuclease activity. Averages shown n=3; error bars, s.e.m. Nuclease 
reaction carried out as described in Figure 3. (C.) Time course experiments with 5nM WT and 50nM 
C771A. WT and C771A exhibit similar cleavage pattern in early time points, but the C771A is unable 
to efficiently cleave at the base at any time point, despite an overall similar rate in nuclease activity. 
Inset: Quantification:Averages shown n=3; error bars, s.e.m. 20% denaturing gel
- - (nM)32 33 34 35
Dna2 WT Dna2 C771A
0 1 2 3 4 5
0.0
0.2
0.4
0.6
0.8
1.0
Dna2 wt (nM)
%
 D
NA
 S
ub
str
at
e 
Re
m
ain
ing
0 10 20 30 40 50
0.0
0.2
0.4
0.6
0.8
1.0
Dna2 C771A (nM)
%
 D
NA
 S
ub
str
at
e 
Re
m
ain
ing
0 1 2 3 4 5
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Time (min)
%
 D
NA
 S
ub
str
at
e 
Re
m
ain
ing Dna2 WT (5 nM) 
32 32
35
- 15s 30s 1’ 5’ 15’ 30’ - 15s 30s 1’ 5’ 15’ 30’
Dna2 WT Dna2 C771A
0 1 2 3 4 5
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Time (min)
%
 D
NA
 S
ub
str
at
e 
Re
m
ain
ing Dna2 C771A (50 nM)
B.
A.
C.
53
  Next, we investigated the cleavage dynamics between 5nM Dna2 WT and 50nM 
C771A in time course experiments. Both WT and the C771A mutant exhibited a similar 
rate of  nuclease activity. However, while Dna2 WT cleaved a majority of  its products at or 
near the base already at the earliest time points, the C771A mutant was unable to cleave 
efficiently at or near the base and instead exhibited cleavage products mainly away from the 
base - even at the latest time points (Figure 4.6C). These data suggest that the integrity of  
the FeS cluster is critical for Dna2 to cleave efficiently at the base of  a 5’ flap.     
  Therefore, due to the fact that, during replication, flap processing is coupled with 
DNA synthesis by Pol δ, a plasmid-based ssDNA substrate which contains a 30 nt long 
ssDNA flap was used in a replication-coupled nuclease assay (performed by Dr. Maryna 
Levikova, UZH) that contains RFC, PCNA, RPA, and Lig1 (Sec. 2.5.4). In this assay, the 
reaction is initiated when the replisome proteins are incubated with the substrate, 
generating a dsDNA open circular DNA intermediate. The open circular DNA 
intermediate can be further converted to a dsDNA closed circular product by the addition 
of  Dna2 and Lig1. If  Dna2 efficiently cleaves at or near the base, further processing by Pol 
δ  through its synthesis or proofreading exonuclease activities will create a ligatable 
substrate that is ligated by Lig1 (Figure 4.7A). As expected, Dna2 WT was able to cleave at 
or near the base, creating a ligatable substrate. In contrast, Dna2 C771A was unable to 
efficiently cleave at the base, which left non-ligatable substrates (Figure 4.7B). Collectively, 
these results suggest that the FeS cluster in Dna2 is essential for regulating its cleavage site 
in vitro. 
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4.2.4 Using Sf9 Iron Incorporation To Characterize hDNA2  
  Until now, our studies focused on yeast Dna2, but in light of  the growing number of  
nuclear FeS cluster proteins that function in various DNA-related activities and the implication of  
some of  these proteins in human disease, we wanted to begin to characterize human DNA2. 
Therefore, using our newly developed Sf9 iron incorporation assay, we first tested to see if  hDNA2 
is a bona fide FeS cluster protein. Across three biological replicates, our results indicate that hDNA2 
is indeed an FeS cluster protein when compared to the FeS binding mutant (C396S) (Figure 4.8).  
   
  In addition, as stated above, FeS cluster protein biogenesis requires CIA machinery 
proteins MMS19 and MIP18 for the specific insertion of  the FeS cluster via an unknown 
mechanism. Therefore, we wanted to develop a transient knockdown system of  CIA machinery 
protein MIP18, taking advantage of  a short-hairpin RNA that targets endogenous Sf9 MIP18. 
Unfortunately the entire Sf9 genome is not annotated; however, starting from a partially annotated 
sequence of  MIP18 found in the Spodobase (Sf9 genome database), we had an shRNA synthesized 
that allows the direct ligation into the pFASTBac1 vector for baculovirus production. To test the 
effect of  Sf9 MIP18 knockdown, we performed Fe incorporation experiments with wild-type 
human DNA2 non/co-infected with the shRNA-MIP18. As a control we used the FeS binding 
mutant DNA2 C396S. In parallel, we also by overexpressing human MIP18, attempted a rescue 
following the knockdown of  the endogenous MIP18. Knockdown of  endogenous MIP18 was 
confirmed by RT-PCR (Figure 4.9C) (Sec. 2.2.7). As expected, DNA2 WT untreated with shRNA 
had efficient iron incorporation in comparison to the FeS binding mutant DNA2 C396S. 
Furthermore, DNA2 WT treated with shRNA saw greatly reduced iron incorporation, with a 
partial rescue with the co-infection of  human MIP18 (Figure 4.9A/B). Taken together, our data 
show hDNA2 to be a bona fide FeS cluster protein that incorporates iron via  interaction with the Sf9 
CIA machinery components.  
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5. Discussion  
Aim 1: Identifying Potential Novel Nuclear FeS Cluster Proteins: RFC5 
   
5.1 RFC5 Interaction with the CIA Machinery 
  In this project, we aimed to investigate whether RFC5 coordinates an FeS cluster 
as a co-factor. As stated before, RFC5 was chosen as a candidate protein due to its 
identification as a potential interaction partner of  MMS19 via mass spectrometry 
experiments and the observed synthetic lethality of  RFC5’s yeast counterpart Rfc3 with 
mms19∆. To confirm RFC5’s interaction with MMS19 and MIP18 we performed co-IP 
experiments in both Sf9 insect and HEK-293T cells, that revealed that RFC5 indeed 
interacts independently with both MMS19 and MIP18 (Figure 3.2). However, when we 
attempted to detect the presence of  iron in RFC5 via 55Fe incorporation assays, our data 
revealed that RFC5 is unlikely to coordinate an FeS cluster as a co-factor. If  RFC5 is 
indeed not an FeS cluster protein, more studies will be required to identify the relevance of  
RFC5’s interaction with the CIA machinery.  
  Considering that nuclear FeS cluster protein biogenesis occurs in the cytoplasm 
via the CIA machinery, it would be important to identify in which cellular compartment the 
RFC5-CIA machinery interaction takes place, as MMS19 has also been shown to localize to 
the nucleus (Ito et al., 2010). Furthermore, it is also entirely possible that the interaction 
was a false positive, but the observed synthetic lethality of  Rfc3 with mms19∆ points to a 
true interaction.  
5.2 RFC5 Is Unlikely to Coordinate an FeS Cluster  
  As noted above, after we confirmed RFC5’s interaction with MMS19 we 
attempted to detect the presence of  iron in RFC5. 55Fe incorporation assays in both yeast 
and Sf9 cells revealed RFC5 did not incorporate iron (Figure 3.4 and Figure 3.7). Considering 
that RFC5 is a member of  a heteropentameric complex, we hypothesized that the other 
small subunits of  RFC could be required for the coordination of  an FeS cluster, as it was 
shown that the four small subunits are required to form the holo-complex (Uhlmann et al., 
1997). The FeS cluster protein XPD must first obtain its FeS cluster before its integration 
into an active TFIIH complex, but our data suggest that this is likely not the case with 
RFC5 (Vashisht et al., 2015). Therefore, our hypothesis is supported by the observation 
that the FeS cluster protein Primase (PriL) first forms its holocomplex with the non-FeS 
cluster containing small subunit (PriS) before its interaction with MMS19 and its 
subsequent coordination of  an FeS cluster, inferred by the equal number of  peptides of  
both the large and small subunits seen in MMS19 interaction mass spectrometry analysis 
(Stehling et al., 2012). Therefore, we attempted to produce baculoviruses for RFC3, RFC4, 
58
and RFC1 to complete the complex. However, this presented the challenge of  obtaining 
approximately equal amounts of  each subunit, due to the need for separate viruses, as our 
previous experiments showed making a single virus using the T2A peptide would not be 
applicable here. As a consequence, we were unable to obtain conditions, to optimally 
express all subunits. In the end, the data we obtained suggested that RFC5 is unlikely to 
coordinate an FeS cluster. However, with addition of  the small subunits (RFC2,3,4) 
perhaps the RFC complex together could coordinate an FeS cluster. The amino acid 
sequence of  the four small subunits were analyzed and revealed that RFC3, RFC4, and 
RFC5 contain a CXXC motif  at amino acids: 230-233, 177-180 and, 152-155 respectively. 
This motif  has been shown to be important for FeS cluster coordination in a number of  
proteins that bind an FeS cluster in a labile fashion. (Bandyopadhyay et al., 2008; Netz et 
al., 2012; Sheftel et al., 2009). Therefore, it is tempting to speculate whether the RFC 
complex may coordinate an FeS cluster also in this fashion.  
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6. Discussion 
Aim 2: Elucidating the Role of  the Iron-Sulfur Cluster in the Nuclease/Helicase 
Dna2 
6.1 FeS Cluster in Dna2 Is Essential For its Nuclease and Helicase Activities  
  In this project, we investigated the role of  the FeS cluster in the nuclease/helicase 
Dna2. The role of  the FeS cluster in Dna2 was previously investigated by Pokharel and 
Campbell, where they confirmed Dna2 to be an FeS cluster protein. Furthermore, their 
biochemical analysis revealed that loss of  the FeS cluster was detrimental to its nuclease 
activity, but caused no defects in DNA binding and protein structure, as indicated by 
limited protease digestion experiments. Interestingly, the loss of  the FeS cluster also 
reduced its ATPase activity, even though the ATPase domain is located in the C-terminal 
helicase domain (Pokharel & Campbell, 2012). Considering the fragile nature of  FeS 
clusters and the threat of  oxidation, coupled with advancements in protein purification and 
FeS cluster biology, we asked whether the integrity of  the FeS cluster was maintained 
during purification in this earlier study. Therefore, we purified Dna2 and various mutants 
with an optimized protocol and tested their biochemical activities in vitro. Our data revealed 
an essential role of  the FeS cluster in mediating both its nuclease and helicase activities. 
6.2 Dna2’s FeS Cluster Is Required For Potent Nuclease Activity  
  As stated before, a previous study on the FeS cluster in Dna2 showed that the loss 
of  the FeS cluster eliminated Dna2’s nuclease activity (Pokharel & Campbell, 2012). 
However, in contrast to this finding, we show that the loss of  the FeS cluster significantly 
reduces Dna2’s nuclease activity, but does not eliminate nuclease activity (Figure 4.3). The 
FeS cluster in Dna2 has largely been considered a structural element, so the reduction in 
nuclease activity could be due to a structural conformational change. However, it was 
shown previously that DNA binding and overall structure was unaffected by the loss of  the 
FeS cluster (Pokharel & Campbell, 2012). In our study, we did not address whether DNA 
binding or structure was affected, but it would be interesting to determine if  our new 
optimized preps behave differently to those from the previous study. In the end, our data 
suggests the FeS cluster in Dna2 is required for potent nuclease activity.   
6.3 Loss of  the FeS Cluster in Dna2 Does Not Stimulate Helicase Activity.  
  Dna2 contains a Superfamily I helicase domain, shown to possess weak 
unwinding capability. However, it was later shown that upon nuclease inactivation, Dna2 
possesses potent helicase activity that is comparable to a number of  other helicases such as 
Sgs1 (Levikova et al., 2013). These data suggested that Dna2’s helicase activity was masked 
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due to potent nuclease activity that cleaves 5’ flaps required for helicase loading. Therefore, 
we hypothesized that the reduction in nuclease activity after FeS cluster loss could 
potentially stimulate helicase activity. Our data showed, that Dna2 has potent helicase 
activity upon nuclease inactivation as expected (Figure 4.4) However, the double nuclease-
dead/FeS (E675A/C771A) and (C771A) mutant exhibited little to no helicase activity, 
indicating that the FeS cluster is required for helicase activity and that the loss of  the FeS 
cluster does not stimulate helicase activity via reduction in nuclease activity (Figure 4.4)  
6.4 The Role of  Dna2’s FeS Cluster in Okazaki Fragment Maturation  
  Dna2 has been shown to be an essential enzyme during DNA replication, where 
it has been shown to function during Okazaki fragment maturation (Budd et al., 1995). The 
general consensus of  Dna2 function during Okazaki fragment maturation was to resect 5’ 
DNA flaps upstream of  Fen1 that are coated by RPA, which results in a shorter substrate 
that is then processed by Fen1. However, it was later shown that Dna2 can cleave at or near 
the base of  the flap without the further requirement of  Fen1 processing, challenging the 
“two-nuclease” model (Levikova & Cejka, 2015). We hypothesized that the integrity of  the 
FeS cluster in Dna2 may be required for cleavage at or near the base, and that the FeS 
cluster may regulate the cleavage site of  Dna2 in Okazaki fragment processing. To test this, 
we used recombinant wild-type and 10 times the concentration of  the FeS binding mutant 
(C771A) Dna2 in a nuclease assay, which utilized a substrate mimicking a structure that 
arises upon displacement synthesis during Okazaki fragment processing (Figure 4.6A) 
(Levikova & Cejka, 2015). Here we show that recombinant Dna2 WT cleaves efficiently at 
or near the base of  the 5’ flap with majority of  cleavage products being 32 nucleotides +/- 
1 nucleotide long. In contrast, Dna2 C771A was unable to efficiently cleave at the base, 
where the majority of  cleavage products are larger than 32 nucleotides, despite a similar 
rate of  nuclease activity (Figure 4.6B). In addition, we performed time-course experiments 
between 5nM Dna2 WT and 50nM C771A. Our data revealed that both WT and the 
C771A exhibited a similar rate of  nuclease activity. Over the course of  the experiment 
qualitative differences in cleavage were observed, where Dna2 WT cleaved a majority of  its 
products at or near the base, even at the earliest time points, whereas the C771A mutant 
cleaved the DNA substrate more indiscriminately, with cleavage products away from the 
base of  the flap - even at the latest time points (Figure 4.6C). These data suggest that the 
integrity of  the FeS cluster is critical for Dna2 to cleave efficiently at the base of  a 5’ flap. 
Next, we tested flap processing coupled with DNA synthesis by Pol δ, using a plasmid-
based ssDNA substrate containing a 30 nt long ssDNA flap, using a replication-coupled 
nuclease assay (performed by Dr. Maryna Levikova, UZH) that contains RFC, PCNA, 
RPA, and Lig1 (Sec. 2.5.4). As expected, Dna2 WT was very efficient in flap processing by 
62
allowing a nearly complete Okazaki fragment maturation, assisted by Pol δ’s polymerase 
and 3’-5’ exonuclease activities. In contrast, Dna2 C771A was unable to efficiently cleave at 
or near the base, which left non-ligatable substrates (Figure 4.7B). Collectively, these results 
suggest that the FeS cluster in Dna2 is essential for regulating its cleavage site in vitro. 
6.5 FeS Cluster in Dna2: A Structural Element?  
  In this project we aimed to investigate the role of  the FeS cluster in Dna2. Our 
results from biochemical analysis revealed the FeS cluster to be critical for both its nuclease 
and helicase activities. Furthermore, the FeS cluster was found to be essential in regulating 
the cleavage site during Okazaki fragment processing in vitro. Taken together, our results 
indicate that Dna2’s activities can be regulated via its FeS cluster. However, a recent study 
of  the the crystal structure of  mouse Dna2 showed that the DNA is threaded through 
Dna2 via a narrow tunnel (Figure 6.1) (Zhou et al., 2015). Therefore, it is possible that the 
loss of  the FeS cluster, which is located in the nuclease domain, could cause a 
conformational change, abrogating the threading of  Dna2 onto DNA, which in turn 
reduces Dna2’s nuclease activity. Furthermore, we saw a significant reduction in helicase 
activity of  Dna2 in the double nuclease-dead/FeS binding mutant (E675A/C771A). Thus, 
it is also possible that this is due to the changes in Dna2’s structure after FeS cluster loss, 
despite the fact the helicase domain is quite distant from the FeS binding domain. 
However, considering the essential role Dna2 plays in replication, the regulation of  Dna2’s 
activities through its FeS cluster could be by design. That is, when the replisome encounters 
DNA damage, local conditions could oxidize Dna2’s FeS cluster, which in turn would 
reduce its nuclease activity and prevent helicase activity, allowing for the slow down of  
from progression so the damage can be repaired, a phenomenon that has been previously 
reported as a means to protect genome integrity (Iyer & Rhind, 2017). However, further 
studies, such as DNA fiber analysis to measure fork progression would be required to 
validate this hypothesis. Although it was tempting to speculate that the redox state of  
Dna2’s FeS cluster plays a role in regulating the interplay between its nuclease and helicase 
activities, our data didn’t support this notion. Moreover, it has been recently shown that 
Dna2 is SUMOylated in its N-terminal domain and that this modification abrogated Dna2’s 
nuclease activity but not its helicase or ATPase activities (Levikova & Cejka, in press). 
Therefore, it is highly likely the interplay between Dna2’s nuclease and helicase activities is 
determined by its post-translational modification status by SUMOylation.   
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6.6 Dna2 Biochemical Analysis Outlook  
  In this study, we investigated the role of  the FeS cluster in Dna2 and how it may 
regulate Dna2’s cellular activities. Our data revealed an essential role in both Dna2’s 
nuclease and helicase activities in vitro. Furthermore, the FeS cluster was critical for cleavage 
site regulation during the processing of  Okazaki fragments. However, to obtain a complete 
picture on how Dna2’s FeS cluster regulates its cellular activities, we’ve identified the 
following experiments that are critical to extend or confirm our preliminary results:  
   
  1. Purification of  Dna2 WT from a mms19∆ background- In this construct, the 
absence of  endogenous MMS19 would allow us to test Dna2 WT without the coordination 
of  an FeS cluster. With this new construct, we can directly compare the biochemical 
activities of  the FeS binding mutant, confirming our results we obtained showing a critical 
role of  the FeS cluster in both nuclease and helicase activities.  
  2. DNA Binding - In our study we did not address DNA binding as it was shown 
not to be affected in a previous study by Pokharel and Campbell (Pokharel & Campbell, 
2012). However, considering the large impact of  the loss of  the FeS cluster on Dna2’s 
nuclease and helicase activities, it will be critical to address whether the reduction in 
nuclease and helicase activity is due to less stable DNA binding.  
helicase
nuclease
ssDNA
FeS cluster
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ADP
Figure 6.1 Crystal Structure of  mDna2 
Crystal structure of  the Dna2-ssDNA complex. 
ssDNA depicted in blue. PDB Code: 5EAX 
(Zhou et al., 2015)  
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  3. RPA Interaction Study- In our Okazaki fragment processing experiments, we 
showed that the FeS binding mutant was unable to cleave 5’ flaps at or near the base in 
comparison with the WT. Considering that RPA has been shown to enhance Dna2 activity, 
we want to address whether the difference in cleavage is not due to a loss in Dna2-RPA 
interaction.  
  4. Role of  FeS cluster in long rage resection- It has been shown that hydrolysis of  
ATP is important for Dna2’s ability to translocate to the base of  a 5’ flap generated by the 
Sgs1 helicase in an exo1∆ background (Miller et al., 2017). Therefore, considering how the 
loss of  the FeS cluster abolished helicase activity, it would be interesting to see if  the loss 
of  the FeS cluster also plays a role in Dna2’s ability to translocate along a 5’ flap, as the 
abolished helicase activity infers a loss in ATPase activity.  
 6.7 Using Sf9 Iron Incorporation To Characterize Human DNA2 
  In our studies we focused on yeast Dna2, but in light of  the growing number of  
nuclear FeS cluster proteins that function in DNA metabolism and the implication of  some 
of  these proteins in human disease, we began to characterize human DNA2. First, we 
confirmed hDNA2 to be a bona fide FeS cluster protein by Sf9 iron incorporation (Figure 
4.8). Next, to test hDNA2 iron incorporation upon the knockdown of  endogenous Sf9 
MIP18, we performed experiments with wild-type human DNA2 non/co-infected with the 
shRNA-MIP18. In parallel, we overexpressed human MIP18 in shRNA treated DNA2 WT 
cells to attempt a rescue following the knockdown of  the endogenous MIP18.(Figure 4.9C) 
(Sec. 2.2.7). As expected, DNA2 WT untreated with shRNA, had efficient iron 
incorporation in comparison to the FeS binding mutant DNA2 C396S. Furthermore, 
DNA2 WT treated with shRNA saw greatly reduced iron incorporation, with a partial 
rescue with the co-infection of  human MIP18 (Figure 4.9A/B). Taken together, our data 
show hDNA2 to be a bona fide FeS cluster protein, that incorporates iron via interaction 
with the Sf9 CIA machinery components.  
  Moving forward we aim to optimize protein expression levels and MIP18 rescue, 
which will allow us to obtain clearer differences in iron incorporation. Furthermore, 
considering that MIP18 was originally identified in a proteome-wide screen for factors that 
contain hyperreactive cysteines (Weerapana et al., 2010), we aim to produce a MIP18 
baculovirus with a point mutation in this cysteine residue, to investigate whether MIP18 is 
involved in the transient binding of  an FeS cluster and the transfer to apoproteins. In the 
end, the Sf9 iron incorporation will allow us to i) identify and characterize known and 
unknown FeS cluster proteins and ii) with the knockdown and rescue experiments further 
elucidate how FeS cluster biogenesis occurs. Collectively, these experiments, will allow us to 
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obtain more information on how FeS clusters in DNA metabolizing proteins function and 
the role they play in preserving genomic integrity.  
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